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Abstract
Many neurological diseases, such as Parkinson’s disease (PD) and epilepsy, can significantly affect
patients’ motor function, often leading to a dramatic loss of their quality of life. Human motion
analysis is undoubtedly regarded as fundamental towards an early diagnosis and an enhanced
follow-up in this type of diseases. In this contribution, NeuroKinect, a markerless system for
human motion analysis in neurological diseases is presented. This system includes an RGB-D
camera (Microsoft Kinect XBOX 360 and Kinect v2 for XBOX One) and two applications, KiT
(KinecTracker) and KiMA (Kinect Motion Analyzer), running in a portable PC, which enable the
acquisition, visualization and management of RGB, depth, infrared, body-index and 3D tracking
data provided by the sensor. The presented system is a portable, low-cost solution, suitable for
use in a clinical environment, which has already been deployed in an Epilepsy Monitoring Unit
(in Munich, Germany) and used in multiple healthcare scenarios. In addition, in the Epilepsy
scenario, a new tool named KiSA (Kinect Seizure Analyzer) makes use of the RGB-D information
from KiT and KiMA to track and quantify uncoordinated seizure movements.
Keywords: RGB-D camera. Kinect. motion quantification, movement-related diseases, Parkin-
son’s disease, epilepsy.
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Resumo
Várias doenças neurológicas, tais como a doença de Parkinson ou a Epilepsia, podem afectar de
forma significativa as capacidades motoras de um paciente, levando a uma perda significativa da
sua qualidade de vida. A Análise do movimento humano é reconhecidamente considerada como
fundamental na obtenção de um diagnóstico precoce e no acompanhamento ao longo do tempo
deste tipo de doentes. Nesta contribuição, o NeuroKinect, um sistema não-vestível para análise de
movimento humano em doenças neurológicas é apresentado. O sistema inclui um sensor RGB-D
(Microsoft Kinect XBOX 360 e Kinect v2 XBOX One) e duas aplicações, o KiT (KinecTracker)
and KiMA (Kinect Motion Analyzer), que aquando instaladas num computador, permitem a ac-
quisição, visualização e manipulação de informação RGB, profundidade, infra-vermelho, presença
de um corpo e dados de esqueleto 3D providenciados pelo sensor. O sistema apresentado é por-
tatil, e é uma solução low-cost, adequada á prática clínica, que foi já implementado numa unidade
de monitorização de Epilepsia (em Munique, Alemanha) e usado em diversificados contextos hos-
pitalares. Além disso, no cenário da Epilepsia, uma nova ferramentada chamada KiSA (Kinect
Seizure Analyser) utiliza a informação RGB-D do KiT e do KiMA para acompanhamento e quan-
tificação de movimentos descoordenados em crises epilépticas.
Keywords: câmara RGB-D. Kinect. quantificação de movimento. doenças do movimento.
Parkinson’s. epilepsia.
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Chapter 1
Introduction
Technologies are now worldwide spread and became an intrinsic part of society. Technology is
also constantly changing and, by now, new types of devices that have different properties than
their antecessors (smaller size, wearable, wireless) are emerging. Everyone can now be a Q-Selfie
(Quantified Self, QS), meaning that an individual can monitor, for instance, its own heart rate
during one night using a wearable t-shirt Cunha et al. [2010]. The QS movement is based on
the self-tracking of any kind of biological, physical, behavioral, or environmental information.
The continuous monitoring of such variables have already been done in high-performance teams
and players, but with a high cost associated. By using this recent and free applications, available
online, everyone can monitor almost everything Swan [2013].
Nowadays, in Healthcare, several medical devices and high powerful processing techniques
are being used, followed by continuous improvements in the DNA research, which is flourishing
new frontiers for disease treatment and diagnosis.
The need for better quality and personalization of the medical care provided by clinical insti-
tutions to patients spiked this interest in medical devices that brought up valuable clinical infor-
mation that until now was not available.
Technology takes a big role in healthcare and by now, besides the state-of-art imaging modali-
ties (magnetic resonance imaging (MRI) or computed tomography (CT)), numerous hospitals have
their owns gait-labs, as well as video-EEG systems to enhance the diagnosis process.
Besides data acquisition, new developments on algorithms for signal processing and method-
ologies for data analysis will allow the extraction of other clinical relevant parameters than can
be interpreted by physicians. With the increase of life expectancy and elderly population, much
attention should be given to the need of constant care provision and follow-up.
Therefore, information technology associated with Healthcare greatly enhances the amount of
information available for the physicians, improving both the efficiency and quality of healthcare
Wu et al. [2006]. In order to provide the best care possible to a patient, the amount of information
available for the physicians should be as much as possible. In diseases where the movement is
impaired, accurate information regarding that same impairment is critical to the diagnosis process.
1
2 Introduction
1.1 Motivation
Many neurological diseases are characterized by movement impairments that affect the patients
quality of life. Often, this patients are carefully followed up by physicians and therefore, accurate
information of the disease progress throughout time is critical.
Most of the times, this information is based on the visual analysis provided by a video-
recording, which only allows a qualitative instead of an accurate quantitative analysis. Movement
analysis of movement-related diseases is typically achieved by using wearable passive-marker
systems, under a controlled environment. Performing such analysis within the normal routine of
an Hospital is a very demanding task (it is necessary room availability, the physicians presence
and overall it is a time-consuming activity), that makes them unsuitable and unpractical for many
healthcare routine environments. For that specific problem, the emergent 3D RGB-D cameras
have already shown greater ability for the development of a markerless based system.
RGB-D cameras are sensing systems that capture RGB images along with per-pixel depth
information, as well as 3D subject tracking data: all of this information is obtained in the most
comfortable way to the patient, since that, for this data acquisition, the sensor only needs to be
placed in front of the patient.
RGB-D cameras characteristics makes them suitable for enhancing the diagnosis process by
supporting the physicians with quantitative information, besides the qualitative analysis that is
already performed by video (visual inspection). The opportunity of using RGB-D cameras for
human motion analysis and quantification, in a markerless way, would be of great value for the
biomedical engineering field as well as for the routine healthcare systems.
1.2 Objectives
In this thesis, the aim is to make a contribution to the development of a markerless based video-
system, based on a low-cost RGB-D camera, that: can be used in the clinical neurology envi-
ronment, in multiple scenarios; allows the acquisition and tracking of the movement and is also
unobstructive to the patients given their health conditions. Thus, systems that use markers or
reflectors, for example, attached to the patient’s body are out of scope of the goal of this thesis.
Firstly, in this document, the state of the art regarding two targeted neurological diseases will
be reviewed and then focus will be pointed onto motion tracking sensors, with particular incidence
on Kinect. Further examples of existing technologies based on the same premise will be also
covered without so much detail. Finally, attention will be drawn to movement quantification, with
particular emphasis in Parkinson’s and epilepsy movement analysis. Chapter 5 addresses KiMA
software and chapter 6 the use of the NeuroKinect system in the healthcare context, whereas in
the final chapter the work developed is reviewed and analyzed.
1.3 Resulted Publications 3
1.3 Resulted Publications
The present thesis resulted in the following publications:
• Ana Patrícia Rocha, Hugo Choupina, José Maria Fernandes, Maria José Rosas, Rui Vaz,
João Paulo Silva Cunha. Parkinson’s Disease Assessment Based on Gait Analysis Using an
Innovative RGB-D Camera System. In 36th Annual International IEEE EMBS Conference
Chicago, USA: 2014 - Accepted for Publication (see Appendix E).
• João Paulo Silva Cunha, Ana Patrícia Rocha, Hugo Choupina, José Maria Fernandes,
Maria José Rosas, Rui Vaz. Sistema de quantificação 3D de movimento portátil e de baixo
custo para estimativa do sub-score de marcha em doentes parkinsónicos. In Sinapse no. 1
volume 14 (2014): 67.
• Ana Patrícia Rocha, Hugo Choupina, José Maria Fernandes, Maria José Rosas, Rui
Vaz,João Paulo Silva Cunha. Estimativa do sub-score UPDRS de marcha em doentes parkin-
sónicos usando um sistema de quantificação 3D de movimento portátil e de baixo custo. In
30o Congresso Nacional da Sociedade Portuguesa de Neurocirurgia.
Some other publications are also being prepared based on some of the contributions here re-
ported.
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Chapter 2
Neurological Diseases
Several neurological diseases produce motion impairments in patients. In the present thesis we
have focused on two of them: Parkinson’s and Epilepsy.
2.1 Parkinson’s Disease
2.1.1 Background
Parkinson’s disease (PD) is named after the London general practitioner, James Parkinson, who
was the first person to describe the “paralysis agitans”, a condition that lately was renamed Parkin-
son Disease by Jean-Martin Charcot.
In his work, where it was described many of the clinical features of the condition (“An Essay
on the Shaking Palsy (1817)”) James Parkinson Essay [1817], James Parkinson refers the medical
condition by the term said above which captures a peculiar characteristic of the disease: the com-
bination of movement loss (also known as hypokinesia) with stiffness (i.e. rigidity) and tremor
James Parkinson Essay [1817].
2.1.2 Modern Definition
PD is an idiopathic progressive neurodegenerative disease that results from the death and degener-
ation of brain cells responsible for producing dopamine. Dopamine Bernheimer et al. [1973] is a
neurotransmitter, released by the brain, that is responsible for a number of important physiological
functions in the bodies of animals, such as movement, memory or behavior and cognition.
The deficiency or excess of this vital chemical molecule is the main cause of several disease
conditions. Dopamine is produced in the dopaminergic neurons in the ventral tegmental area
(VTA) of the mid-brain, in the substantia nigra pars compacta, and also in the arcuate nucleus of
the hypothalamus.
This lack of dopamine results in a dysregulated motion action, which is controlled by the basal
ganglia (responsible for the movement function), that depends on a certain amount of dopamine
to function at peak efficiency. The process occurs via dopamine receptors, and, every time that
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Figure 2.1: Parkinson’s Disease Flowchart on the Health Systems Requirements throughout the
disease progression WHO [2006].
there is a deficiency of the molecule in the brain, movements may become impaired Schultz [2007]
Fellous and Suri.
2.1.3 Health and Social Implications
An estimated seven to ten million individuals worldwide have PD 1. This number is expected to
rise significantly in the future Dorsey et al. [2007], with 60,000 new cases being currently reported
every year only in the U.S.
Information from WHO WHO [2006] states that there is a higher prevalence and incidence of
PD in males. Incidence increases with age, but an estimated four percent of people with PD are
diagnosed before the age of 50.
The progression of the disease varies among different individuals, meaning that symptoms
continue and worsen over a period of years. Over this time, patients autonomy is lost and that
affects themselves as well as their carers quality of life. The left-side of Figure 2.1 provides a
flowchart on health systems requirements as the disease progresses.
2.1.4 Symptoms
PD is characterized primarily by movement dysfunctions and with time cognitive functions are
also affected. People that present Parkinsonism symptoms often demonstrate hypokinesia, akine-
sia, bradykinesia, rigidity and tremor NCC [2006]. Impaired postural balance is often frequently
reported.
1Parkinson’s Disease Foundation http://www.pdf.org/
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The most debilitating ones are hypokinesia and akinesia. Studies reported that other impair-
ments could also include dystonia and dyskinesias NCC [2006] Hausdorff [2009].
Hypokinesia is characterized by the decrease in body movement, and its effect is more no-
ticeable when the individual is requested to do movement sequences such as walking, writing and
speaking or even when performing multiple tasks that require self-coordination.
Akinesia is the inability to initiate movement due to the degeneration of the brain cells re-
sponsible for selecting and activating the correct motor programs. The impact in the patient life is
tremendous since he loses autonomy in routine tasks such as standing, dressing and even speaking.
Bradykinesia is referred to the slowness of movement and it is also associated to other disor-
ders of the basal ganglia. It is also associated to what is normally referred as “stone face”, typical
in PD patients.
Tremor is an involuntary muscular contraction often seen in PD and its one of the earliest
symptoms to arise. It is very tricky to assess since tremor does not affect tremendously the patient
life and it easily disappears during voluntary’s movements. Resting tremor in PD can occur as an
isolated symptom or can be seen accompanied by others.
Rigidity is also one of the primary symptoms of PD and refers to stiffness and resistance of
movement in a body part. Rigidity may occur in the neck, shoulders, hips, ankles or hands NCC
[2006] Hausdorff [2009] Jankovic [2008]. Figure 2.2 presents some of the symptoms describe
above, as well as other typical impairments, such as the shuffling gait.
2.1.5 Diagnosis
The initial symptoms of the disease usually manifest after mid-age of the individual. PD can
also be caused by drugs and less common conditions such as multiple system atrophy (MSA)or
progressive supranuclear palsy (PSP) NCC [2006]. The disease is mainly a movement disorder,
but in fact other impairments frequently develop, such as the ones seen on the right side of Figure
2.1.
Medical imaging is a tool that cannot be applied in diagnosis, since MRI and CT scans of the
patients appear normal. In addition, there are no definitive biological or imaging markers that can
be used in the imaging process WHO [2006].
The brain changes that occur are microscopic, on a chemical level, and they are not revealed
by these scans NCC [2006]. Physicians assessment is then based on the patient history and also
stringent clinical criteria. Expert physicians are intimately familiar with the characteristic history,
signs and symptoms found when examining a person with PD. They then must judge how closely
the history of symptoms and the neurological findings (from the physical examination) of any
specific person match those of typical PD.
A specific exam that is often made is the evaluation of movement after the intake of PD medi-
cation (i.e. carbidopa-levodopa). If significant improvement happens, the diagnosis of PD will be
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Figure 2.2: Parkinson’s Disease Systematic Symptoms 2
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confirmed NCC [2006]. Additional exams may be also realized, but to exclude other diseases that
imitate Parkinson’s disease, such as stroke or hydrocephalus 3.
2.1.6 PD Rating Scales
The progress of PD is different in each individual, and, physicians have tools that helps them
understand the evolution during continuous follow-up consults, using rate-scales. This analysis is
critical to assess the severity of the movements impairments and how much the disease affects a
person’s daily activities.
The state of motor function in patients with PD is commonly characterized by the Unified
Parkinson Disease Rating Scale (UPDRS), whereby motor functions such as tremor, hypo-brady-
akinesia, rigidity of hand and arm movements are examined and classified on five discrete levels of
severity ranging from 0 to 4. The scale is divided in five levels, each one regarding different aspects
of the patient life and autonomy. There is one section fully dedicated to the gait impairments (part
III). The UPDRS scale is used to follow the progression of the disease and also to measure possible
benefits of specific treatments and medications 4.
2.1.7 Gait Disturbances in PD
PD is characterized by movement dysfunctions, usually the continuous (CGD) and episodic gait
disturbances (EGD). EPD are occasional and intermittent, which act in a random way. Still there
is no scientific explanation for their occurrence.
EGD includes festination (i.e. involuntary tendency to take short accelerating steps), hesitation
and also freezing of gait.
CGD are alterations on the normal movement pattern that are persistent and easily spotted over
time. Increase of stride length and gait variability are some of the normal alterations associated
to this impairment Ebersbach et al. [1999] Morris et al. [1996] Morris et al. [2000]. Hausdorff
Hausdorff [2009] reports that the mechanisms responsible for both continuous and episodic events
are in some way independent of each other even though they result from the dysfunctions of the
basal ganglia.
2.1.8 Treatment
Nowadays, there is still no cure for PD, but there are ways to help control the disease. The goal
of the treatment is to provide a better quality of life for as long as possible. Patient quality of life
deteriorates quickly if no treatment is applied after a positive diagnosis.
Pharmacological treatment help in controlling acuities directly related to the motor symptoms.
This therapy can be classified into: symptomatic and neuroprotective. Usually, the Pharmacologi-
cal treatment is based on levodopa (combined with a dopadecarboxylase inhibitor or with COMT
3Parkinson’s Disease Foundation http://www.pdf.org/
4European Parkinson’s Disease Association: Unified Parkinson’s Disease Rating Scale (UPDRS)http://www.epda.
eu.com/en/parkinsons/indepth/parkinsonsdisease/rating-scales/updrs/
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inhibitor), dopamine agonists and MAO-B inhibitors Fellous and Suri Fahn et al. [2004] Hausdorff
[2009].
These drugs should be used in the early stages of the disease, in the hope of delaying the
frequency of dyskinesias. Improvements of symptoms might occur during this treatment but over-
time, the benefit of using drugs frequently becomes less consistent.
Physicians recommend that, in the early stages, lifestyle changes should be implemented to-
wards helping the improvement mainly of the motor symptoms, such as increasing the physical
activity. Aerobic exercises not only improve balance and postural control but can make the patient
feel more relaxed, and overall, provide a sense of comfort Hausdorff [2009]. When medication is
not effective anymore, other available solution is the DBS surgery. DBS is a surgical treatment
where electrodes(or neurostimulators) are implanted inside the brain for stimulating specific zones
of the brain. Two areas may be stimulated: the subthalamic nucleus (STN) or the internal globus
pallidus (GPi) Hausdorff [2009]. There structures are the ones involved in motor control. After
the implantation of DBS, patients have a much greater control over their body movements.
DBS does not cure the disease, but it can help managing some of the symptoms and there-
fore improve the patient quality of life 5. Other breakthrough treatment strategies involve gene
therapy’s, stem cells treatment, neural transplants or even brain infusions 6.
2.2 Epilepsy
2.2.1 Background
Epilepsy is a neurological condition which affects the nervous system. Epilepsy is commonly
referred as seizure disorder. Seizures are caused by disturbances in the electrical activity of the
brain. The cause of this seizures may be related to a brain injury or a family history, but most of
the time it is unknown. An estimated 65 million people have epilepsy, with 150.000 new cases
being reported each year in the USA 7, whereas in the European Country the number of people
that suffers from the disease is above 5 million 8.
2.2.2 Modern Definition
An epileptic seizure is a temporary and transient occurrence of signs due to abnormal brain activity.
This disease is characterized by a person’s predisposition to generate epileptic seizures, and by
the neurobiological, cognitive, psychological, and social consequences of this disease. Seizures
origin’s is believed to be an electrochemical disorder in the brain cells, causing an imbalance of
the regions of the brain which are excited or inhibited by the same brain cells. The seizure is then
5European Parkinson’s Disease Association: Deep Brain Stimulation http://www.epda.eu.com/en/parkinsons/
in-depth/surgery/deep-brain-stimulation/
6Surgical Treatments from the European Parkinson’s Disease Association: http://www.epda.eu.com/en/parkinsons/
in-depth/surgery/
7An introduction to Epilepsyhttps://www.epilepsy.com/start-here/introduction-epilepsy
8Statistics by Country for Epilepsy http://www.rightdiagnosis.com/e/epilepsy/stats-country.htm.
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Figure 2.3: Epileptic Seizures electroencephalography (EEG) pattern.
characterized by the sudden appearance of uncontrolled electrical activity in the brain, affecting
the way the people feel’s and acts during, typically, a short amount of time. Some seizures might
go unnoticed by the patient, where numbness might be felt, whereas in the most common seizures,
the person might go unconscious, and experience uncontrolled body movement Fisher and Saul
[1997].
2.2.3 Types of Seizures
Seizures have been classified in terms of the patient behavior during the seizures. Typically, they
are divided first into two categories: partial (focal) and generalized.
Partial seizures have onset on one side of the brain, resulting in focal symptomatology such
as twitching in an arm or face, a sensory change, or even the focal type of change in memory that
occurs with temporal lobe seizures and frontal lobe seizures. This kind of seizure can alter the pa-
tient memory or even its consciousness over a short period of time. They are usually characterized
by twitching, abnormal sensations, distortions of perceptions and uncontrolled body movement
Fisher and Saul [1997].
On the other hand, generalized seizures apparently start on both sides of the brain. In fact,
this kind impairs consciousness and distorts the electrical activity of the whole or a larger portion
of the brain. Typically, generalized seizures are associated to seizures with sudden and very short
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Figure 2.4: Epileptic Seizures EEG patterns depending on the type of seizures: Partial or Gener-
alized 9.
duration of jerking in the body extremities Fisher and Saul [1997] 10.
2.2.4 Semiology of Epileptic Seizures
The state-of-art classification of epileptic seizures is based exclusively on the ictal seizure semi-
ology, and was divided into five branches: aura, autonomic, dialeptic, motor and special seizure.
This classification was performed only by 2D video analysis Lüders et al. [1998] Noachtar and
Peters [2009].
Each kind of seizure is characterized by certain phenomena and so, seizures in which the main
manifestations are motor activity were named as motor seizures. Figure 2.5 shows the full table
of the semiological seizure classification.
Within the motor seizures, two major groups are differentiated: the simple and the complex
motor seizures. On one hand, the simple motor seizures movements are relatively "‘simple"’,
unnatural and are characterized by movements similar to the ones obtained when electrically stim-
ulating the primary areas of the brain responsible for the motor functions.
On the other hand, the complex motor seizures are named after the complexity of the move-
ments being presented, which simulates natural movements, but are inappropriate, unexpected and
unintended from the patient Lüders et al. [1998] Noachtar and Peters [2009].
Each simple and complex motor seizures are then divided into subgroups, whereas each sub-
group is characterized by a different muscle activity of the individual. The simple (myoclonic,
10Epilepsy Health Center http://www.webmd.com/epilepsy/guide/types-epilepsy
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Figure 2.5: Semiological Seizure Classification (Adapted from: Noachtar and Peters [2009]).
tonic, epileptic spams, clonic, tonic-clonic and versive seizures) are all characterized by short pe-
riods of muscle activity, whereas the complex motor seizures (hypermotor, automotor and gelastic
seizures) are known for complex movements, with considerable duration, involving the proximal
segments of the limbs and trunk Lüders et al. [1998] Noachtar and Peters [2009].
2.2.5 Epilepsy Triggers
Seizure occurrence is unpredictable and therefore, a seizure can occur at any time. Nevertheless,
keeping track of biological and environmental factors that may trigger a seizure can help in the
process of identifying when a seizure will arise.
Some triggers are easily perceived and can arise at any time, even during sleep or when wak-
ing up. Others may be triggered by highly stressful situations, alcohol, drug abuse or sleeping
deprivation 11.
Common epilepsy triggers are:
• Specific time of day or night;
• Flashing bright lights or patterns (gaming for long hours, which is very common in younger
ages);
• Specific foods, excess caffeine or other products that may aggravate seizures;
11Epilepsy Triggers http://www.drugs.com/health-guide/epilepsy.html
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Figure 2.6: Normal electrocardiography (ECG) + EEG Signal.
2.2.6 Diagnosis
Knowing if a person is having a seizure and diagnosing the type of seizure can be extremely
difficult. There are many other disorders that can be easily confused with epilepsy. Nevertheless,
accurate descriptions of seizure events are insufficient to clearly attest epilepsy, and so, imaging
tools are critical in order to learn more about the brain, what is causing the events and where is the
source of the problem.
Epilepsy is usually diagnosed after a person has had at least two seizures that were not caused
by some known medical condition Fisher and Saul [1997]. Besides this criteria, information of
the medical history, blood tests, EEG analysis, and brain imaging tests such as CT and MRI scans
are fundamental in providing physicians with critical information for an accurate diagnosis.
EEG (electroencephalography) is the tool for the analysis of the brain’s electrical activity.
Electrodes are attached to the patient scalp and connected by wires, which allow the recording of
the brain’s electrical activity as a series of squiggles called traces. Each trace corresponds to a
different region of the brain. EEG shows patterns of normal or abnormal brain electrical activity.
Figure 2.6 shows the typical output from an EEG recording and figure 2.7 presents the unusual
electrical activity during a generalized seizure. When an EEG test picks up unusual electrical
activity, it shows the areas of your brain where it is coming from.
EEG acquisition is now frequently associated and synchronized with video-recording of the
seizure, namely Video-EEG systems Specchio et al. [2011]. This modality provides the EEG
signal combined with the video, which is tremendously important in case of epileptic seizures.
When using such a system, besides the typical EEG signal, the seizure can be also qualitatively
analyzed in terms of the motion pattern. This pattern can be visually perceived by an experienced
physician 2.8.
Analyzing the motion pattern of the seizure can provide the physicians with critical informa-
tion towards an accurate diagnosis: the motion pattern may reveal the seizure onset point or source
(location inside the brain responsible for the seizure), as well as identify the presence of an actual
seizure and also the type of seizure (see Figure 2.9).
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Figure 2.7: Normal EEG Signal of Generalized Epilepsy 12.
Figure 2.8: "‘Stills from video-EEG recording. 1) Micturating; 2) forward flexion of upper trunk
and extension of upper extremities, and a beta burst (arrow) at Cz electrode; 3) fall and attenuation
of the EEG activity (arrow); and 4) rhythmic 2 Hz spike and wave discharges at Cz electrode
during postictal phase"’ Rathore et al. [2008].
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Figure 2.9: "Ictal video/EEG recording during a typical episode of yawning. The EEG of the
episode shows low-to medium-voltage fast activity over bilateral central areas lasting a few sec-
onds, followed by rhythmic spikes and polyspikes involving bilateral central and frontal areas
during which the patient yawns. Multiple artifacts related to mouth movement and tongue protru-
sion are also evident. A prolonged subclinical sequence of spike-and wave complexes is evident
over frontal and central areas after the artifacts. Arrows indicate the correlation with the snapshot
of the video."’ Specchio et al. [2011].
Medical Imaging is another critical tool in a clear assessment of Epilepsy. Magnetic Reso-
nance Imaging (MRI) is used to visualize the brain’s internal structures in detail, producing high
resolution images of the brain.
MRI imaging can be used as an extremely precise imaging tool, for the detection of brain
aneurisms, strokes or brain tumors. Besides that, this imaging technique is often used for studying
the brain’s anatomy and also as a reference for the mapping and spatial co-registering with others
imaging modalities Warach et al. [1996].
Positron Emission Tomography (PET) is an functional imaging technique which makes use of
radioactive tracers (i.e. radiotracers) to produce three-dimensional images of functional processes
in the body. Pairs of gamma rays emitted indirectly by the tracers, which is introduced into the
body on a biologically active molecule, are detected and used to construct high-resolution images.
PET is often used in Epilepsy due to greater spatial resolution and versatility in tracking mul-
tiple tracers and therefore, imaging various aspects of cerebral function at the same time Spencer
[1994].
SPECT (Single photon emission computed tomography) is an imaging technique used to lo-
calize the region of seizure onset for epilepsy surgery planning, using ictal and interictal scans.
SPECT has recently emerged as a valuable adjunct to standard techniques in clinical nuclear ra-
diology, in which SPECT can help in significantly improving the scintigraphic localization and
characterization of a region, which is tremendously important in this era of minimally invasive
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Figure 2.10: MRI Brain Scan 13
Figure 2.11: PET Scan Spencer [1994]
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Figure 2.12: SPECT images 14
surgery and targeted radiotherapy. This technique has the outstanding and unique advantage of
mapping the brain activity when the radiotracer is injected, at the time of the seizure, and the ac-
tual imaging can be done later on when the patient is stable. The radiotracer is rapidly taken up
by the brain based on the cerebral blood flow (CBF) and does not spread itself through the brain
McNally et al. [2005] Kim et al. [2001]. CBF is very important since it is closely related to the
neuronal activity, and so, the SPECT injection provides a living proof of the brain activity at that
specific time McNally et al. [2005]. ISAS (Ictal – Interictal Spect Analysis by SPM) basic idea
is to compute the difference between an ictal and interictal SPECT scan for a patient Kim et al.
[2001].
Ictal images represent the brain activity at the moment of seizure and the interictal are obtained
within 24hours of the seizure end, being images that portrait the brain activity during a stable phase
of the patient. Significant increases and decreases in CBF between the two moments can then be
detected, and the differences are computed against a healthy normal database to determine the
variation Kim et al. [2001], providing information in the localization of the epileptogenic region
McNally et al. [2005].
2.2.7 Treatment
The majority of epileptic seizures are controlled through drug therapy. These are sometimes called
anti-epileptic drugs or anti-seizure drugs. They will successfully control seizures for about 7 out of
10 people with epilepsy. The type of treatment prescribed will depend on several factors including
the frequency and severity of the seizures as well as the person’s age, overall health, and medical
history.
Surgery is an alternative for some people whose seizures cannot be controlled by medication.
The benefits of surgery should be weighed carefully against its risks because there is no guarantee
that it will be successful in controlling seizures. The surgery goal is to remove the brain part
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which is thought to be responsible for the rise of the epileptic seizures and therefore, by removing
it, seizure frequency is expected to diminish 15.
15Epilepsy Treatments https://www.epilepsy.com/learn/treating-seizures-and-epilepsy/surgery
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Chapter 3
Movement Analysis and Quantification
Movement analysis is the study of movement, and in a more specific case, study of human motion,
using visual perception of people and also complex video-systems (with sensors measuring body
movements and body mechanics) to study the biomechanical activity. Human motion analysis is
normally used when there is a need to assess, for instance, the walking acuities of an individual
and, based on the information retrieved, set a treatment plan to enhance their ability to walk Gavrila
[1999].
With the continuous developments of technology, more areas started to use the information
retrieved from the body and so, such analysis can also be used, for example, in sports Biomechan-
ics to help professional athletes improve their overall performance. Movement analysis consists
mainly in two different aspects: quantification and interpretation of movement. Quantification
is related to the specific parameters, for instance speed, acceleration or cadence, and interpreta-
tion enables to draw different conclusions based on the subject information (i.e. age, height, size,
disease) Gavrila [1999] Lee and Grimson [2002].
The introduction of video-systems, which enabled detailed studies of patients with relatively
good accuracy, it led to the development of treatment strategies, mainly involving different depart-
ments, from the neurosurgeons to the orthopedic and rehabilitation physicians. Nowadays, several
hospitals have their owns gait labs, as well as video-EEG systems, to perform routine consults and
follow-up monitoring, besides designing treatment plans Davis III et al. [1991]. Computers are
now becoming a crucial element in such analysis, since that, provided with a video-recording of
barely any kind, it can put out critical information regarding certain features that can be of extreme
relevance for that specific scenario. Despite this developments in technology, such systems are still
not an essential tool in diagnosis and rehabilitation that had the potential to be Baker [2007]. Nu-
merous factors contributed to this: prohibitive costs in technology, time consuming tests, results
lack of clinical interpretation and validation.
Biomedical engineering has sought to address these same problems by creating new techniques
that can capture data in a much more rapidly and efficient way. The result of this effort has resulted
in evolving from the traditional kinematical systems (film analysis, chronophotography) to mod-
ern techniques such as video-based systems and more recently the new modern optoelectronics,
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beyond the typical force platforms1.
Movement can be affected by many factors, and these acuities can be temporary or even per-
manent. The factors can be of several types: extrinsic (i.e. footwear, clothing), intrinsic (i.e.
sex, weight, height, age), physical, psychological or even pathological (i.e. neurological diseases,
musculoskeletal anomalies). The common features that can be extracted from human movement
analysis are: velocity and accelerations of body parts, angles, distances between body parts and
many others. In the specific case of gait, the typical features are: stride length, cadence, gait speed,
acceleration, foot angle, joint angles, stride-to-stride variability and swing timeLee and Grimson
[2002].
The analysis of the movement patterns can be performed in 3 different ways: a biomechanical
anthropometric analysis, Kinematical analysis and Electromyography. Recently, thermography is
emerging as a promising way to also quantify movements.
3.1 Passive marker-based motion capture systems
Active and passive markers are used when a multi-camera system is implemented. The cameras
utilize infrared signals and then, based on the angle and time delay between the original and re-
flected signals, triangulation of the marker in space is possible. It also enables the computation of
joint angles Morris et al. [1999] Sofuwa et al. [2005]. Such devices can measure the position, may
be portable and may even transmit data in real-time, however and are prone to noise and interfer-
ence from metal objects, besides being expensive. On the other hand, marker-based approaches
are very precise and highly accurate but also very expensive. In this case, the subject is surrounded
by cameras that, additionally, need to be calibrated. It is an adaptable and minimally intrusive but
it is physically limited because of the need of a gait laboratory.
Passive marker-based tracking systems use reflective-markers - small plastic support covered
with retro-reflecting material and its goal is the skeleton reconstruction of the 3D motion of a set
of markers. Those markers do not require any powering, are hardly sensed by the subjects and
appear much brighter than the background allowing their detection, on the video images. Never-
theless, the system is quite robust, not portable, and expensive that involves cameras, connections,
computers and displays. Current commercially available full body motion capture systems (e.g.
Vicon 2 and Qualysis 3) usually rely on a predefined skeleton model with a small number of mark-
ers, which have fixed positions on the tracked subjects. Correct placing markers at anatomical
landmarks minimizes sliding and allows regression based methods for the localization of joints, as
it can be depicted in Figure 3.1.
In such systems like the Qualysis or the Vicon, as referred before, multiple cameras observe a
target moving around a pre-determinaded path. Features on the target are identified in each image.
Triangulation or disparity can be used to compute each feature’s 3D position. The pipeline of the
1AMTI Force Platforms http://www.amti.biz/fps-overview.aspx
2Vicon System http://www.vicon.com/
3Qualysis Motion Capture Systems http://www.qualisys.com/
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Figure 3.1: Anterior and posterior view of markers placement general scheme (red – fixed markers
for dynamic full body analysis; green – markers for static view; yellow posterior view).
analysis consists of 1) Camera set-up and calibration; 2) Recording; 3) Marker identification; 4)
3D Reconstruction where the multiple set of 2D data have to be correctly labeled and associated
to their corresponding 3D markers; and 5) Clean-up post-processing Moeslund et al. [2006].
The drawbacks of such systems in terms of performance can come from two major sources:
low resolution which results in poor features identification; and occlusion which results in failure
to see the feature. Occlusion may be due to either the target itself or other objects in the scene,
for instance, when a marker is hidden to the cameras by any body part. That is why this system
use multi-cameras, so that occlusion can be reduced. Other disadvantage is the dependence on
scene illumination Moeslund et al. [2006] Chen and Davis [2000]. However, the main difficulty is
the correct synchronization between multiple markers and multiple cameras. Also, the dense set
of markers gives rise to the possibility of them coming very close to one another at times during
data collection Chen and Davis [2000]. Recently, RGB-D sensors emerged as markerless systems
capable of performing motion analysis.
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Figure 3.2: VICON F40 motion capture system.
3.2 RGB-D Sensors
The RGB-D (Red, Green, Blue, Depth) sensors are usually divided into two broad categories,
depending on the depth measurement: time-of-flight cameras and structured-light systems.
The 3D Time-of-Flight (ToF) is an emerging imaging technology which adds a new dimension
to the imaging world. The cameras equipped with this technology capture the lateral as well as
the depth information of an imaging 3D scenario. The camera works on the principle of Time-of-
Flight wherein the distance towards any imaging point in 3D space is calculated according to the
travel time of the rays hitting the sensor pixel. This technology provides an easy and fast way of
capturing 3D information which is of prior interest among the new generation image and video
processing systems Hansard et al. [2013].
Basically, a ToF produces a depth image where each pixel encodes the distance to the corre-
sponding point in the scene; it is a range imaging camera system that resolves distance based on
the known speed of light, measuring the time-of-flight of a light signal between the camera and
the subject for each point of the image.
These cameras can then be used to estimate a 3D structure directly, without using complex
computer-vision algorithms, which is a tremendous advantage. Besides, only one camera is re-
quired, no manual depth computation is needed (it is a direct measurement), as well as it is not
Figure 3.3: Classification of Depth Measurement Techniques Castaneda and Navab [2011].
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Figure 3.4: Time-of-Flight Cameras Depth Estimation Process Fuchs and Hirzinger [2008].
dependent of the background illumination since its influence is limited by the light pulses, and
also the fact that the illumination and observation directions are collinear. As downsides of this
technology, it requires high-accuracy time measurement, can be affected by light scattering and
there is a difficulty in generating light pulses with fast rise and fall times Fuchs and Hirzinger
[2008]. Practical applications for this sensing modality include robot navigation, human-machine
interaction and 3D reconstruction.
Examples of ToF based RGB-D sensors are the DepthSense Cameras – DS311 and DS325,
as well as the Panasonic D-IMager and the recent Kinect For Windows version 2(K4W) sensor.
DS311 device delivers real time 3D distance data mainly for far interaction (full body tracking),
but it can also be used for close interaction. It can provide depth data at a distance of 15cm, up
to 60fps. It is composed of ToF sensor, RGB sensor and two microphones. The device, combined
with IISU Middleware platform, provides several functionalities that can be both implemented for
commercial or scientific applications.
DS3254 is the most accurate depth sensor in the market. It is aimed to be used into close
interaction applications (hand and finger tracking). It has a higher RGB resolution and field-of-
view comparing with DS3115.
4DS 325 http://www.softkinetic.com/Portals/0/Documents/PDF/WEB_20130527_SK_DS325_Datasheet_V3.0.pdf
5DS311 http://www.softkinetic.com/Portals/0/Documents/PDF/WEB_20130527_SK_DS311_Datasheet_V3.0.pdf
Figure 3.5: DepthSense DS325.
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Figure 3.6: DepthSense DS311.
Panasonic D-IMager is another ToF 3D sensor, launched by Panasonic Eletric Works. D-
IMager uses a proprietary CCD along with near-infrared LEDs to sense human gestures and track
full body motion allowing users a fully interactive experience. This Sensor enables precise motion
capture of spatial objects with wide field-of-view by processing high precision (pixel by pixel)
data. It works at an approximate rate of 15-30 fps with a 160×120 resolution. The main advantage
of this sensor is the range that varies from 1.2m to 9.0m. ToF cameras differ from structured-light
systems as the KinectTMsensor and Asus Xtion Pro Live.
At this moment, ToF cameras, even though they can provide a much more accurate depth im-
age and are able to deal better with shadow effect, their price (i.e. hundreds of dollars), noise
in depth information (substantially higher) makes it some-how not suitable in the quest of imple-
menting a low-cost markerless video-system for movement analysis.
Asus Xtion Pro Live is an alternative hardware sensor for motion-tracking. The device is based
on the same hardware as Kinect, both produced by PrimeSense. Xtion is largely similar to Kinect
in its functionality. The cameras and sensors installed closely follow the movement of the person
in front, extrapolating and even recognizing key spots, all in real time. Like Kinect, all this data
can then be processed in PC software. A major drawback of Asus Xtion Pro Live is that due to
the nature of the hardware, it needs to be placed ideally in the middle of the display length when
viewed horizontally (i.e. in top of a TV or monitor). One of the differences between the two
devices is the quality of the RGB camera, which is higher in Asus Xtion Pro Live7.
7ASUS Xtion PRO LIVE http:www.asus.com/Multimedia/Xtion_PRO_LIVE/
Figure 3.7: Panasonic D-IMager 6.
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Figure 3.8: Asus Xtion Pro Live.
3.3 Kinect XBOX 360
KinectTMwas launched as a non-contact motion sensing device by Microsoft for the Xbox 360
video game console back in November 2010 Melgar and Diez [2012]. KinectTMis the result of
combining technologies from Microsoft Game Studios owned by Microsoft and PrimeSense, an
Israeli developer Melgar and Diez [2012]; Webb and Ashley [2012]; Catuhe [2012].
It was quickly discovered that depth sensing technology could be used for other purposes be-
sides gaming and at a much lower cost than traditional 3D-cameras. KinectTMsensor breakthrough
technology and inherent functionalities, built-in in their SDK, were immediately noticed by ev-
eryone, resulting in being the fastest selling consumer electronics device and worthy a Guinness
World Record 8.
Since its release, KinectTMsensor has been used widely in many research areas such as biomed-
ical engineering, human-computer interface and robotics. The KinectTMhardware would be noth-
ing without the software that makes use of the data gathered. In June 2011, Microsoft released
KinectTMSoftware Development Kit (SDK), which allows the user to write Kinect applications in
different languages such as C++, C# or Visual Basic. Several communities developed immediately,
where users could interact and develop software open-source (i.e. OpenNI and OpenKinect).
3.3.1 Kinect Basic Principles
Kinect is composed by a horizontal bar connected to a small base with a motorized pivot. The
device characteristics include a RGB camera, a multi-array microphone and depth sensor. The
video camera helps in facial recognition and in the detection of other features just by detecting the
three color components red, green and blue.
Depth is assessed by using an infrared projector and a monochrome CMOS (complimentary
metal-oxide semiconductor) sensor that combine to see the space in 3D, independently of the
lighting conditions Webb and Ashley [2012]. The principle behind the Kinect depth sensor is the
emission of an IR pattern and the image capture of the IR image with the CMOS camera that filters
the image.
The image processor of the device uses the relative positions of the dots in the pattern to
calculate the depth displacement at each pixel position in the image Webb and Ashley [2012],
8Microsoft Kinect,: World’s Fastest-Selling Consumer Electronics Devicehttp://www.huffingtonpost.com/2011/03/
09/microsoft-kinect-fastest-selling-consumer-electronics_n_833706.html
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Catuhe [2012], Andersen et al. [2012]. The depth image from the IR camera has a maximum
resolution of 640 x 480 pixels with 11-bits, which provides 2 048 levels or sensitivity.
The Microsoft Kinect is a RGB-D camera that provides three different types of data, at 30 fps:
• Color (1280×960 at 12 frames per second (fps), 640×480 or 320×240 resolution);
• Depth (640×480, 320×240, or 80×60 resolution);
• Skeleton information of 20 body joints (Figure 3.9).
Figure 3.9: Kinect v1 Joint List.
The IR or depth camera has a field of view just like any other camera. The original purpose
of Kinect is to play video games within the confines of a living room space, at a certain nominal
distance. The normal depth vision ranges from around 800mm to just over 4000mm Webb and
Ashley [2012]. However, a recommended usage range is 1500mm to 3500mm as the reliability of
the depth values degrade at the edges of the field of view Andersen et al. [2012]. At 2m from the
sensor, it is able to resolve down to 3 mm for height and 1 cm for depth. The sensing range of the
depth sensor is adjustable, with the possibility of Near Mode range or Default range. Nevertheless,
the depth resolution of KinectTMcoarsens as the distance increases Catuhe [2012] Andersen et al.
[2012].
3.3 Kinect XBOX 360 31
Figure 3.10: Kinect XBOX 360 Vision Sensor.
3.3.2 Sensor Properties
• Linearity
KinectTMsensor has several properties. One of them is linearity. Linearity of the sensor can
be analyzed by pointing the sensor perpendicularly to a planar surface and in the measuring
range of the sensor, determine if the depth estimates are close to the actual distance. It
is a fact that in the measuring range of the sensor depth estimates are accurate and that is
particularly relevant when performing qualitative analysis of the acquisition using the sensor
Andersen et al. [2012].
• Depth Accuracy and Precision
Depth accuracy and precision can be affected by errors mainly related to the lighting condi-
tions and the imaging geometry. Light condition affects the contrast in the infrared image
and imaging geometry is related to difficulties in determining the object distance and orien-
tation relative to the sensor Andersen et al. [2012], Khoshelham and Elberink [2012].
Khoshelham et al. analyzed the accuracy and resolution of Kinect depth data for indoor
mapping applications and concluded that for mapping applications the data should be ac-
quired within 1–3m distance to the sensor and that the depth resolution decreases quadrat-
ically with an increase distance from the sensor. In addition, Khoshelham et al. proposed
Figure 3.11: Kinect Color and Depth acquisition: IR and RGB physical locations Zollhöfer et al.
[2011].
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a mathematical model for obtaining 3D object coordinates from the raw depth image mea-
surements Khoshelham and Elberink [2012] Han et al. [2013].
• Structural Noise
The depth estimates in the depth image describe the distance from the point to the sensor
plane rather than the actual distance from the point to the sensor. This should result in the
same depth estimate over the entire image if the sensor is pointed directly at a planar surface.
However, there are small variations over the image.
These variations that occur mainly on the edges of the objects are called structural noise.
Noisy edges are used to determine the spatial precision of the sensor, as it was done in
Andersen et al. work Andersen et al. [2012]. Structural noise is a measurement error that
can affect qualitative analysis when using the sensor. Its filtering and removal is of extreme
importance Han et al. [2013].
• Multi-Camera Setup
Depending on the type of experiment desired, there is a need for a second (or more) KinectTMsensors.
This allows a larger field-of-view and also to record an object from more than one viewpoint.
Despite this possibility, many problems arise from the use of multi-cameras. One of those
problems is that multiple sensors may interfere in the image formation of each other, by
overlapping their IR pattern and making it impossible to estimate the depth. This overlaps
are often called blind spots and unexpectedly KinectTMcan overcome this error with an error
of 1-5"%" of the correct value Melgar and Diez [2012].
The major problem when using multi-sensors is the low response that the computer pro-
vides the user. Each sensor requires USB connection + external power. If both sensors are
connected in the same USB controller the device might not work correctly. In order to ef-
fectively use two KinectTMdevices, multiple USB Controllers are required. Normal laptops
only have one USB Port. When both devices are connected into a single laptop, the USB
bandwidth is exceeded and that disables the device abilities.
• Shadows in the depth image
The quality of the depth-map image can be affected by light conditions. One of the recurrent
problem is related with the creation of shadows due to the distance between the illuminator
and the IR camera illuminated objects. The appearance of this shadow hampers the ability
of the sensor to estimate the depth and therefore the pixels in that particular area are set to
zero depth. Figure 3.12 explains the formation of this shadow Andersen et al. [2012] Han
et al. [2013].
Figure 3.13 explains shadow formation in the depth image. The presence of this shadow
does not allow the sensor to estimate the depth and therefore the pixels in that particular
area are not assigned to any specific value Andersen et al. [2012]. Table 3.1 presents a table
with an overview on the Kinect XBOX 360 sensor.
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Figure 3.12: Shadow formation process using Kinect Andersen et al. [2012].
Figure 3.13: The object in the figure blocks the path of the laser. Since the depth estimate is based
on the pattern projected by the laser, Kinect cannot estimate depth outside the line of sight of the
laser Andersen et al. [2012].
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Table 3.1: Kinect Requirements Overview
External Power Required Yes
Angular Field of View Horizontal 57o | Vertical 43o
Sensorization RGB and Depth Sensors, Microphone Array, Accelerometers
Resolution RGB and Depth: 640 x 480 pixels @ 30 Hz
Platform At least dual-core 2.66-GHz processor, 32/64 bit, 2GB RAM
Interface Dedicated USB 2.0
Software Microsoft Kinect SDK , OpenKinect, OpenNI and OpenCV
Programming Language C#, C++, Visual Basic, Java, Python, ActionScript
Dimensions 30 cm x 7.6 cm x 6.4 cm
Notes Motor tilt from -27o to 27o
3.4 Kinect for Windows (K4W) v2
Kinect for Windows Developer Program Preview enabled research groups and developers to be
provided with the alpha version of the new Kinect sensor, expected to be released to the market by
the end of 2014. BRAINlab was one of the first 500 selected groups being granted with one such
sensor, which can be depicted in figure 3.14 9.
The recent sensor is still under development, with monthly releases of updated SDK’s and
so far, not much information can be released on the physical, as well as inner properties of the
sensor (BRAINlab signed a non-disclosure agreement). Nevertheless, the new sensor has been
re-engineered with major enhancements in the near mode, wider field-of-view, optimized skeletal
tracking algorithm (built-in inside the SDK), API improvements, improved USB support, and two
new different streams from XBOX 360: besides the normal color, depth and skeleton (now referred
as body) stream (available with the SDK), the new Kinect v2 includes the infrared (IR) and also
the "‘bodyindex"’ (per-pixel position of the player) stream.
The sensor is optimized for use with computers running Windows 8.0 or 8.1. The major
developments regarding the Kinect XBOX 360 and the Kinect v2 are related to a higher resolution
of the color stream (1920 x 1080 High-Definition), the depth estimation process, since the Kinect
v2 is now a ToF (time-of-flight) sensor, and the overall improvements in the SDK functionalities
10. Additionally, instead of the typical 20 joints available on Kinect v1, the newer version now
tracks 25 joints, as can be depicted in figure 3.15. Table 3.2 presents a table with an overview on
the Kinect for XBOX One version 2 sensor.
9Kinect for Windows (K4W) v2 Joint List http://www.codeproject.com/Articles/213034/
Kinect-Getting-Started-Become-The-Incredible-Hulk
10Kinect for Windows (K4W) v2http://www.microsoft.com/en-us/kinectforwindowsdev/newdevkit.aspx
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Figure 3.14: Kinect for Windows version 2 available for the project thesis.
Figure 3.15: Kinect for Windows version 2: 25 Joints Collection Enumeration.
Table 3.2: Kinect v2 overview.
External Power Required Yes
Sensorization RGB and Depth Sensors, Microphone Array
Resolution RGB : 1920 x 1080; Depth, Infrared and BodyIndex:
512 x 424 pixels @ 30 Hz
Platform 4 GB Memory (or more), i7 2.5Ghz (or higher)
Interface Built-in USB 3.0 host controller
Software Microsoft Kinect SDK v2
Programming Language C#, C++, Visual Basic, Java, JavaScript
Dimensions 24.9 cm x 6.6 cm x 6.7 cm
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3.5 Gait Quantification in Parkinson Disease
Gait disturbances in PD include several features which are not easily quantified in normal obser-
vations; these are caught after an effective quantitative evaluation using video-systems that record
the gait of the patient. Using this systems, conclusions can be drawn on the left-right gait asymme-
try, bilateral coordination, stride-to-stride variability and also the ability of the person to produce
a steady gait rhythm. Stride-to-stride variability (inconsistency of stepping) is a characteristic of
PD patients and is of interest for numerous reasons. It is a feature that can be seen throughout
the disease, and its magnitude tends to increase with time. It can then be assessed in two differ-
ent moments: the first, where features like gait speed and swing time are measured numerically,
and a second moment, independent from the stride length, composed by the gait/stride-to-stride
variability Hausdorff [2009].
The quantification of motor signs can be very useful to enhance both PD diagnosis and follow-
up Chen et al. [2011]; Cancela et al. [2011], and possibly lead to an improvement of treatment and
overall life quality of PD patients.
Gait analysis in PD, using motion or vision sensors, has been studied by various authors Chen
et al. [2011]; Cancela et al. [2011]; Galna et al. [2014]. In Cancela et al. [2011], the authors
proposed a PD monitoring tool, based on six accelerometers and one gyroscope. Based on sensor
data collected from PD patients, they extracted parameters that can be useful for distinguishing
between on and off states.
A vision-based system for PD assessment (distinction between non-PD, PD drug on and PD
drug off states) was proposed in Chen et al. [2011]. The authors recorded videos of PD patients and
normal subjects while walking. A minimum distance classifier was then built, based on features
resulting from gait analysis, which achieved an accuracy of 80.5%.
Recently, the Microsoft KinectTM has been used for gait analysis Galna et al. [2014]; Gabel
et al. [2012]; Stone and Skubic [2011], Rocha A [2014]. The KinectTM, as explained in the
previous chapter, is a low-cost, portable RGB-D (Red, Green, Blue, Depth) camera that provides
color and depth image sequences, as well as skeleton data resulting from 3D tracking. This sensor
has the advantage of being less intrusive than marker-based sensors. Moreover, when compared
with RGB cameras, it allows motion analysis in less controlled environments, due to the use of
infrared light, without losing accuracyStone and Skubic [2011].
Regarding PD, the validity of the KinectTM for movement measurement in PD patients was
recently explored inGalna et al. [2014]. When compared with a Vicon system, the sensor was
able to accurately measure time and gross spatial characteristics of clinically relevant movements,
validating its use for gait analysis in the healthcare context, namely in PD.
3.6 Movement Quantification in Epilepsy
It is common that uncoordinated movement is experienced by a patient when an epileptic seizures
is induced. This movement is a important clinical factor in seizure identification. Nevertheless,
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quantification of this information has not been an object of much attention from the scientific
community. The state-of-art approach is analyzing the video-EEG monitoring of such events.
Although movement is very important in the diagnosis of epilepsy, for many years, efforts have
concentrated on developing quantification algorithms to extract EEG features, which cannot be
seen in traditional visual inspection, instead of processing the video information, easily perceived
by visual inspection.
The reasons for these rely on the fact that visual analysis allows only a rough estimate of the
motion pattern and also the fact that capturing, storing, and processing video data demands enor-
mous throughput from computers. Nevertheless, seizure motion pattern quantification of Epilepsy
movements is regarded by the physicians as valuable evidence in the identification of the presence
of a seizure and of its source.
To address this complex problem, the common-approaches to human body quantification rely
on model-based and model-free methods. Model based approaches use the information from body
parts such as joints to reconstruct 3D models, using depth and skeleton information, and per-
form quantification based on that. On the other hand, most of the model-free approaches use
binary silhouette (also known as background subtraction) techniques for human body detection
and recognition, and from there predict the body movement Kumar and Babu [2012].
In Sofuwa et al. Sofuwa et al. [2005], a quantitative gait analysis was made during the on-phase
of medication cycle and the measures obtained (in terms of spatiotemporal, kinematic, and kinetic
gait parameters) were compared to a healthy control group. Gait analysis was conducted using an 8
M-camera Vicon 612 data capturing system set at 120Hz and 3 AMTI forceplates mounted midway
on an 8-m walkway. Statistical analysis using a t-student distribution and ANOVA showed lower
walking velocity and stride length in PD patients Sofuwa et al. [2005]. A gait analysis system
that uses a Kinect was developed in Gabel et al. [2012]. Regression models were built based on
skeleton data, and ground truth measures (using in-shoe pressure sensors and a gyroscope), which
were collected from subjects while walking. The obtained models were able to estimate stride
duration and arm angular velocity, with an average absolute error in the range between 32 and 71
milliseconds, and 14 and 22 degrees/second, respectively Gabel et al. [2012].
Even though these approaches are suitable for their target applications, they cannot be used to
extract quantified information for more complex human motion, such as the epileptic movements.
The movement induced by epileptic seizures is complex, uncoordinated, unpredictable and is,
thus, extremely difficult to model and quantify. Throughout the time, several works have been
done with this purpose. The state-of-art approach to Video-EEG Analysis, performed by Li et
al., in a clinical neurophysiology environment, using a monochrome CCD camera with several
infrared light mounted right above the bed at an approximate distance of 1.5m is presented in
figure 3.16.
Infrared reflective markers are attached to landmark points of the body (22 in total) and the
setup is assumed that the motion of the seizure will be registered at all times by the video system.
Movement quantification is performed by saving the video data files.
The motion information is processed using the QMovES software, and its divided in two
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Figure 3.16: The setup of QMovES System. A CCD camera acquires video sequences into a PC
where a digital video-EEG system and the QMovES software tool are installed Li et al. [2002].
Figure 3.17: 22 landmark positions defined for the full-body marker positioning system Li et al.
[2002].
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main stages, the initialization and the tracking of the markers. The tracking of the marker is
modulated as a two-dimensional (2D) ballistic motion, preceded by a Kalman filter to predict
marker positions. Figure 3.18 represents a schematic of the procedure.
Figure 3.18: Schematic representation of the procedure for movement quantification used in
QMovES Li et al. [2002].
The results from QMovES is the 2D movement in both horizontal and vertical axis (X and
Y), in terms of pixels units. The authors succeeded in quantifying the motion, in terms of speed
and spatial motion patterns, using the markers informationLi et al. [2002]. Based on this initial
work, Cunha et al. developed a similar approach, to evaluate seizure semiology. The setup for this
approach can be seen on figure 3.19.
The setup includes an infrared CCD camera and an infrared LED lamp installed over the bed.
Videos from simulation trials and real seizures were recorded and the movement quantification
was performed using the pipelines from Li Li et al. [2002] and the MaxTraq software 11. The
authors were able to successfully segment and quantify jerking arm’s movements, which are a
typical MOI in the late clonic phase of the "‘tonic-clonic"’ seizure type Cunha et al. [2003].
Karayiannis et al. proposed the extraction and quantification of temporal motion velocity sig-
nals in video recording of neonatal seizures by optical flow methods Karayiannis and Tao [2003];
Karayiannis et al. [2005a,b].
Optical flow is the term used to indicate the velocity field generated by the relative motion
between an object and the camera in a frame sequence. Assuming that the optical flow estimations
11Software Maxtraq http://www.innovision-systems.com/Products/MaxTraq.html
40 Movement Analysis and Quantification
Figure 3.19: Video setup geometric model. Adapted from Cunha et al. [2003].
are a reliable approximation of the two-dimensional image motion, this algorithm can be used in
many different applications, such as to recover the three-dimensional motion of the visual sensor
as well as determining the three-dimensional surface structure (shape or relative depth), perform
motion detection and object segmentation Horn and Schunck [1981] Barron et al. [1994].
Optical Flow can also be referred as the distribution of apparent velocities of movement of
brightness patterns in an image, therefore providing important information about the spatial ar-
rangement of the objects viewed and the rate of change of this arrangement Horn and Schunck
[1981] Karayiannis and Tao [2003]. Typically, the optical flow computation is based on two suc-
cessive frames, thereby being an ill-posed problem. An ill-posed problem is characterized by the
fact that its solution might not be unique and its solution does not depend continuously on the data
Karayiannis and Tao [2003].
Let I = I(x,y,t) be the continuous space-time frame intensity distribution. If the pixel intensity
remains constant along a certain direction, then its derivative is zero:
dI(x,y,t)
dt
= 0 (3.1)
.
This condition can then be re-written as:
∂ I
∂x
∗u+ ∂ I
∂y
∗ v+ ∂ I
∂ t
= 0 (3.2)
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where u,v denote the components of the coordinate velocity vector in terms of the continuous
spatial coordinates Karayiannis and Tao [2003].
This equation is also known as the optical flow equation (OFE). The OFE equation is not
enough to specify the 2-D velocity field. There are several ways of solving the OFE equation, such
as the Phase-Correlation, Block-Based Models, and the most traditional ones (Horn–Schunck and
Lucas-Kanade), based on partial derivatives of the image signal and/or the sought flow field and
higher-order partial derivatives Karayiannis and Tao [2003].
Global methods (i.e. Horn–Schunck) usually use a smoothness regularization term, to compute
dense optical flows over large image regions. Local methods (i.e. Lucas-Kanade) use normal
velocity information in local neighborhoods to perform a least squares minimization to find the
best fit for the velocity constraint Barron et al. [1994].
Barron et al Barron et al. [1994] provides an extensive review on the computation of the optical
flow algorithms. The Horn–Schunck method advantages is that it yields a high density of flow
vectors, even though it can be more sensitive to noise than the local methods. On the other hand,
the Lucas-Kanade is a very powerful algorithm for the calculation of the flow, but since it is a local
method, it cannot provide the flow information in the interior of uniform region within an image
Horn and Schunck [1981]; Barron et al. [1994].
In Karayiannis and Tao [2003], the author presents a procedure to quantify seizures, where the
motion at a certain frame t=t0 was quantified by the maximum velocity of the region of the frame
that contained the moving body part. After this initial approach, Karayiannis et al. developed
their pipelines in order to recognize and characterize seizures. Their work involved three main
tasks: extraction of quantitative motion information from video recordings of seizures, in form of
motion-strength and motor-activity signals, selection of quantitative features that convey unique
characteristics of neonatal seizures, and finally training artificial neural networks to distinguish
neonatal seizures from normal infant motion and also to differentiate myoclonic and focal clonic
seizuresKarayiannis et al. [2005a]. The outcome of their experiments verified that optical-flow
methods are indeed a promising tool for quantifying seizures from video recordings.
O’Dwyer et al. aimed at quantitatively evaluating the lateralizing significance of ictal head
movements of patients with temporal lobe epilepsy (TLE), using the same setup from Cunha et al.
This clinical study investigated thirty-eight seizures (31 patients) with TLE. The head movements
were quantified by selecting the movement of the nose in relation to a defined point on the thorax
in a defined plane facing the camera. Authors statistical analysis showed that ipsilateral movement
always preceded contralateral movement, with a 100% positive predictive value in both directions
of the head movement. They concluded that there is high lateralizing value of ictal lateral head
movements in TLE seizures O’Dwyer et al. [2007].
In the work of Chen et al., quantitative and trajectory analysis of movement trajectories in
supplementary motor area seizures of frontal lobe epilepsy was performed using video analysis
from ten patients. From the trajectories, amplitude, frequency, proximal/distal limb amplitude
ratios, and shoulder/abdominal amplitude ratios measurements were calculated using MATLAB.
The patients used markers, similarly to the setup of Li et al. Li et al. [2002]. Statistically significant
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Figure 3.20: System setup with the 4 high-speed SVCams to achieve a 3D motion tracking system
for seizure movements. A data-station processes the massive information coming from the cam-
eras and feeds pre-processed data to the workstation where the MOIs are analyzed Cunha et al.
[2012].
differences were found in the average amplitude, as well as proximal/distal limb amplitude ratios,
in SMA seizures when compared with those of temporal lobe seizures Chen et al. [2009].
Mirzadjanova et al. evaluated the significance of lateralization of ictal upper limb automa-
tisms in TLE seizures, where features like the duration of the automatisms, movement speed,
extent, length and predominant frequencies of the movements were analyzed in both upper ex-
tremeties of the patient body. Results shown that ipsilateral automatisms were more predominant
than contralateral automatisms, even though no statistical significance was found in the analysis
of the features described above Mirzadjanova et al. [2010]. Similar analysis was used in Rémi
et al. [2011], where quantitative analysis of movements during epileptic seizures was used to iden-
tify objective movement parameters characteristics to distinguish hyperkinetic seizures from other
motor (especially automotor) seizures. Recently, a new 3D approach for movement quantification
of epileptic seizures was proposed by Cunha et al Cunha et al. [2012]. Based on the 2D previous
works Li et al. [2002]; Cunha et al. [2003], the authors now present a revolutionary approach,
using 4 high-speed SVCams to achieve a 3D motion tracking system for seizure movements, as
depicted in figure 3.20.
In order to evaluate the feasibility of the 3D approach, both the 2D and the 3D techniques
were tested in two different scenarios: a simple motor execution performed by a volunteer and
a complex motor motion induced by a real seizure. To quantify the movement of the subject, a
set of spherical infrared reflective markers were attached to anatomic points of the patient, and
MaxTRAQ 2D software, as well as Vicon Workstation software were used to quantify the 2D and
3D movement, respectively. Results clearly demonstrated the superior ability of the 3D approach,
which is expected to have higher impact in the study of more detailed clinical studies in the fu-
ture, relying in the implemented multimodal synchronized system (3D movement + video + EEG)
Cunha et al. [2012].
Chapter 4
Summary and Proposed Methodology
Motion detection is the process of detecting a change in the position of an object relative to the
surroundings or vice-versa, which can be achieved in several different ways. Accurate motion de-
tection and tracking is then critical, and the movement quantification results are highly-dependable
of the detection and tracking stage.
In this thesis, the aim is to make a contribution to the development of a markerless based
video-system, based on a low-cost RGB-D camera, that: can be used in the clinical neurology
environment, in multiple scenarios; allows the acquisition and tracking of the movement and is
also unobstructive to the patients given their health conditions. Thus, systems that use markers or
reflectors, for example, attached to the patient’s body are out of scope of the goal of this thesis.
For this purpose, the type of cameras that fit the best these requirements are RGB-D sensors such
as the KinectTMand the KinectTMv2.
This thesis was divided into three major milestones:
1. Development of KiMA software in a multi-disciplinary environment;
2. Implementation and Usage of KiMA in multiple Healthcare scenarios;
3. 3D Quantification of Neurologic Diseases based on MOI’s previously segmented using
KiMA.
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Part II
NeuroKinect: A Kinect-based System
for Movement Analysis and
Quantification in Neurological Diseases
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Chapter 5
NeuroKinect: A Kinect-based System
for Movement Analysis and
Quantification
This chapter will be divided into three major branches: the first part, KiMA software will be
addressed; in the second part, attention will be drawn on the different pipelines developed in order
to use the streams of information in a different environment (from Microsoft Visual Studio C#
to Matlab); and finally, results which derived from the use of KiMA in a healthcare context, for
the selection of moments of interest (MOI’s), will be presented for the Parkinson’s and Epilepsy
scenarios.
5.1 NeuroKinect, KiT and KiMA
The concept of using Kinect for movement analysis for epilepsy diagnosis was introduced by
PhD João Paulo Cunha that developed with Eduardo Dias the KiT, KinecTracker. KiMA,Kinect
Motion Analyzer is then a companion software to KiT, currently being continuously developed by
a PhD student Ana Rocha, under the supervision of PhD João Paulo Cunha. Figure 5.1 presents
the user-interface of KiT.
KiMA developers were Ana Rocha (aprocha@ua.pt) and Hugo Choupina, with constant su-
pervision of both João Paulo Cunha and José Maria Fernandes (IEETA, Aveiro University). A
special contribution to KiMA is also attributed to Eduardo Dias.
KiT and KiMA together compose NeuroKinect, a motion analysis system based on a RGB-
D Camera, namely a Microsoft Kinect, which connects to a portable computer through an USB
connection. Both applications were developed in C#. KiT is used to acquire and save to file
information about human motion activity, composed of color, depth and skeleton streams 5.4.
The KinecTracker v1 application allows the acquisition of three different sources:
• Color (1280×960 resolution at 12 frames per second (fps), 640×480 resolution at 30 fps,
or 320×240 resolution at 30 fps)
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Figure 5.1: KinecTracker v1 UI.
• Depth (640×480, 320×240, or 80×60 resolution at 30 fps)
• Skeleton of a single subject (20 joints listed in Figure 3.9)
KiMA allows the visualization and the manipulation of the data collected using KinecTracker.
This software is expected to fulfill the need for manipulating the data retrieved from KinecTracker
and it is thought to become an important tool for the Healthcare Environment where it is already
being used.
5.1.1 KiMA Requirements
KiMA is a companion tool to KinecTracker that allows the visualization and manipulation of
information previously acquired by using the KinecTracker with a Kinect. KiMA runs in Windows
Operating Systems, using the Microsoft SDK 1.5. The main requirements defined for KiMA are
the following:
1. Offline visualization of previously acquired streams of information (color, depth, skeleton,
infrared or body-index) - task attributed to Ana;
2. Video manipulation (play, pause, rewind, next frame, stop, frame-rate speed) - task at-
tributed to Ana;
3. Indication and management of relevant instants(labels) and events (MOIs) - task attributed
to Hugo;
4. Exporting of data corresponding to a selected event - task attributed to Hugo.
Consequently, the author’s contribution to KiMA were the inception, design and implementa-
tion of requirements 3 and 4.
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Figure 5.2: KiMA Use-Case Diagram for Kinect v1.
5.1.2 NeuroKinect Architecture
KiT (developed by JPC and Eduardo Dias) primary actor is the Kinect sensor, which was addressed
previously. Using KiT, multiple streams of information can be saved to file and then use KiMA
for the analysis. KiMA (developed by Ana and Hugo) main actor is the physician or the engineer,
depending on the aimed task. Inside this analysis, due to the out-breaking and resourceful capabil-
ities of the sensor, the system can be applied in multiple scenarios. Inside the Epilepsy use-case,
KiSA (will be addressed in the next chapter) is a prototype of a plug-in for KiMA towards motion
analysis in epileptic seizures. One third party of the system might be a remote cloud service, such
as ABRiLTafula S [2014], where information of patient’s movement can be stored and then be
assessed to use with KiMA (Figure 5.4).
5.1.3 KiMA Application
This software is intended to be user-friendly, and so, interacting with it should come naturally.
Nevertheless, some concepts need to be understood before beginning data manipulation.
• Label –> unique moment in time. (i.e: the patient entered the room).
• Event –> unique moment in time that has a beginning and an end. (Begin –> the patient
seizure started; End –> the seizure ended)
• Image Flip –> it can be done Horizontally as well as Vertically, just by clicking in the option
on the Main Window.
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Figure 5.3: NeuroKinect Use-Case Diagram.
Figure 5.4: NeuroKinect Architecture Rocha A [2014].
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• Video Manipulation Shortcuts –> set of mouse-binding features aimed at ease the inter-
action with the software.
– Play/Pause – space
– Forward Frame – right arrow
– Previous Frame – left arrow
– Stop - s
• Tree-View –> Displays in the UI Main-Window all information regarding the Moments of
Interest.
Figure 5.5 shows KiMA Main Window, with a loaded acquisition.
Figure 5.5: Main Window UI of KiMA application, including the display of color, depth and
skeleton data and the mouse-binded Context menu.
KiMA’s main window UI includes a menu and tool bars, visualization area (with primary and
secondary sources), and Options panel. In addition, there are regular video manipulation options
(play, pause, stop, rewind, fast forward, previous and next frames, and frame-rate speed). There is
also a video progression bar, corresponding to the slider located above the manipulation buttons.
The current timestamp and frame number are shown on the right side above the slider.
KiMA allows the indication of labels and events corresponding to MOIs, for further analysis.
A label represents a given time instant, and an event has a beginning and an end. They are visually
represented in the white rectangular area above the progress bar, using different colors to distin-
guish between them, as can be seen in Figure 5.7. Furthermore, the associated information (name
and description) is displayed in the Tree-view below the Options panel.
52 NeuroKinect: A Kinect-based System for Movement Analysis and Quantification
Figure 5.6: KiMA activity diagram.
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Figure 5.7: KiMA UI: At the right-side, the tree-view information regarding all labels and events.
The manipulation and creation of MOIs may involve a few steps. For that purpose, the first
step consists in choosing an acquisition for offline visualization (requirement 1). This is possible
by indicating the location of the folder and the session name containing the desired acquisition,
in the Options panel. If there are more than one acquisitions available, the user should select the
acquisition via selecting the associated date and time.
When the loading is completed, the information regarding the timestamp of the data collected
is placed on the right bottom corner. At this time, you can also see that there is a slider, frame-
dependent: you can use this slider to jump frames within the video play.
Analyzing Figure 5.7, in the tree-view it can be seen two events and within each event several
labels. The same information is displayed above the video manipulation buttons, with different
colors: light orange are the events and dark red the labels. Each label inside each event represents
a specific moment, and in this case, each label is synonym of the person step, right or left. Be-
sides the steps, there is also another label that indicates the moment when the person entered the
room and the field-of-view of the sensor. This example is the typical analysis performed when
partitioning gait cycles within a gait acquisition, using the KiMA software.
After opening an acquisition, it is possible to manipulate the video as in a normal video player,
corresponding to requirement 2. Then, the user can save MOIs by creating labels at certain video
instants, and events with a given duration, using the context menu shown in Figure 5.5. When
creating a label/event, the user must indicate a name and a description (optional). This information
is saved to a XML file, and can be viewed in the tree-view of KiMA’s main window (see examples
shown in Figure 5.7). As can be seen in the Figure 5.5, it is also possible to delete and even
edit labels/events. These functionalities address requirement 3. These features of the software are
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Figure 5.8: KiMA New Label Example: the user must name the event, but an additional descrip-
tion is optional.
binded within the right-button click of the mouse. There is no difference between activating the
right-button click on the primary and the secondary source.
For events, it is further possible to export them as files or PNG images, for further analysis
(requirement 4). This functionality is expected to be used to select seizures in epilepsy, and to
partition gait cycles in PD, for example. To export an Event, the option “Export Event” must
be selected within the right-button click and the user is required to create a New Folder, which
is where the information regarding that MOI will be stored. If the option was "‘Export Event
as Files"’, after the Export is completed, this particular event can be loaded, as it was explained
before. These files follow the same structure defined for KiT (header + file content, in bytes or
integers, in the case of skeleton). Depending on the kind of stream, the header information can be
slightly different. To synchronize all the streams, each different frame corresponds to a different
timestamp, equal for all streams.
If the option was "‘Export Event as Images"’, multiple folders will be created, depending
on the available information (see Figure 5.13). The name of each created frame matches the
timestamp of the moment of acquisition.
Whenever any kind of manipulation is performed (i.e. gait cycles partition), the information
is displayed in the tree-view and also saved in a XML file, which can be seen in Figure 5.9. This
information is structured two main nodes, Labels and Events. Inside each node, the information
regarding each node is stored. The XML organization is fundamental and it allows an enhanced
analysis when there is a need to use the information from KiMA in another environment.
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Figure 5.9: KiMA XML Example: XML organization after the analysis of an acquisition.
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Figure 5.10: KiMA v2 Use-Case Diagram, with the two new streams: Infrared and BodyIndex
.
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Figure 5.11: KiMA v2: Depth, Color and Body streams
.
5.1.4 KiMA for Kinect v2
Since there are incompatibility issues regarding the use of multiple "‘Microsoft Kinect"’.dll com-
ponents (SDK’s) in one single C# solution, KiT and KiMA for Kinect v2 were separately devel-
oped from KiT and KiMA for Kinect v1. KiMA v2 was developed once the KiMA for v1 was
completed. Since the official SDK for version 2 is not completely developed and available to de-
velopers yet, KiMA v2 is being continuously developed, with the monthly releases and updates of
the SDK. Figure 5.11 shows the KiMA v2 UI with the depth view on the primary source and the
High-Definition color in the secondary source.
Analyzing Figure 5.11, it can be perceived the difference in the depth estimations between the
two sensors, as well as the number of joints and the different field-of-view available in the color
stream. Comparing KiMA v1 to KiMA v2, there are no major differences: the only noticeable
ones are the new previously reported streams available in Kinect v2 (Infrared and BodyIndex, see
Figure 5.12), 25 joints available instead of 20, and finally, when exporting an event as images, two
new folders will be created, addressing the two new streams (see Figure 5.13).
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Figure 5.12: KiMA v2: BodyIndex, Infrared and Body streams
.
Figure 5.13: KiMA v2: Folder data Organization when exporting Events
.
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5.2 Kinect 2 Matlab Dynamic Linked Library (DLL)
In this section, the Dynamic Link Libraries (DLL)s of functions (created in order to use the streams
of information in a different environment - from Microsoft Visual Studio C#) developed in Mi-
crosoft Visual Studio C#, using the Kinect SDK and the Microsoft Libraries will be addressed.
The .NET Framework is a development platform for building apps for Windows, Windows Phone,
Windows Server, and Microsoft Azure. It consists of the common language runtime (CLR) and
the .NET Framework class library, which includes classes, interfaces, and value types that sup-
port an extensive range of technologies. The .NET Framework provides a managed execution
environment, simplified development and deployment, and integration with a variety of program-
ming languages, including Visual Basic and Visual C#. .NET framework enables the compiling of
different pipelines, using public interfaces to interact with the compiled code 1 .
5.2.1 KinectforMatlab.dll
Once any event is successfully exported from KiMA, whether in the format of files or images, in
some cases it is required to use the Kinect SDK functionalities for the enhancement of the analysis.
Developing this pipelines is a need since that the Kinect SDK is incompatible with Matlab and so,
for instance, it would be impossible to know per-pixel depth values without this pipelines.
Bearing that in mind, functions for both Kinect v1 and Kinect v2 acquisitions were designed,
implemented and fully-tested.
All functions were built-in in one single *.dll file to ease the user experience in installing the
file in the computer. There are three types of functions available inside the *.dll:
1. functions that return the header information of the files, one for Kinect v1 and one for Kinect
v2;
2. functions that return the bytes information of the streams (color, depth, infrared and bodyin-
dex), one for both sensors;
3. functions that return the depth information of the files, one for each sensor;
4. help functions to understand how to use and access each different function.
More details on the installation of the *.dll and how to access it from Matlab are provided in
Appendix A.
1Microsoft .NET Framework http://msdn.microsoft.com/en-US/library/zw4w595w.aspx
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Chapter 6
NeuroKinect usage in the Healthcare
Context: Practical Examples
The developed software throughout the year is suitable to be used as a video-capture and primary
analysis system in very different scenarios, such as gait analysis, posture control or even for upper
body members tracking. Due to its characteristics, the system (KiT and KiMA) was an integrant
part of the developed work in several different scenarios, namely: Parkinson’s, Epilepsy, FAP
(paramiloidosis) and in the follow-up of rehabilitation strategies on neurological patients. In this
chapter we will describe the usage of the resulting system in different neurological diseases.
6.1 Parkinson’s Disease
Patients that suffer from PD usually show freeze-of-gait, difficulty in maintaining cadence speed
and also variability in the stride length. In this scenario, the work developed aimed at, besides the
typical quantification of each patient’s gait, estimating their clinical gait sub-score (UPDRS motor
part sub-score) and differentiate PD from NON-PD (controls), based on the patient’s gait analysis.
At the same time, since this was an introductory study, another goal was to clearly assess whether
the developed system could be used as an important diagnosis tool in supporting the diagnosis and
follow-up of PD patients.
For that purpose, an experimental protocol was carried out in a room at São João University
Hospital (Porto, Portugal), with the participation of three PD patients (P1, P2 and P3) and three
control subjects (N1, N2 and N3). Each PD patient had an implanted DBS stimulator, and per-
formed the experiment twice: with the stimulator on (STIM ON); and a few minutes after turning
off the stimulator (STIM OFF). Each control subject performed the experiment only once.
The protocol included the use of the Kinect XBOX 360 and the KiT application, to acquire
skeleton data (at a 30 fps rate) from PD patients and control subjects, while they were walking.
The walking trajectory of four meters is illustrated by an arrowed dashed line in Figure 6.1. This
figure also includes the relevant distances, as well as the Kinect height and tilting angle in relation
to the horizontal plane (perpendicular to the gravity force). The chosen setup took into account
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the Kinect limitations, and aimed at maximizing the actual tracking area, which is represented by
the grey rectangle in Figure 6.1.
Figure 6.1: Experimental setup used for data acquisition, including the coordinate system associ-
ated with the Kinect.
The data acquired within the tracking area were firstly manually selected, and then partitioned
into gait cycles, based on depth data acquired at the same time as the skeleton data. The MOI’s
selection, at this stage, was manually done just due to the fact that KiMA was being developed
and so, in order to proceed with the analysis and the software development, the decision was to do
it manually.
Among the several quantitative gait parameters calculated, the variance of the center shoulder
velocity presented the highest discriminative power to distinguish between non-PD, PD ON and
PD OFF states (p = 0.004) Rocha A [2014]. In terms of the UPDRS sub-score estimation, the best
result was achieved for the average distance between ankles (r = -0.85) and also for the median
speed of the right ankle Cunha [2014].
Our work here reported contributed to the publication of two very-short papers in two renown
Portuguese Medical Conferences and, most importantly, to the publication of an international
paper in the world’s most credited Biomedical Engineer Conference (EMBC 2014 - see annex).
6.2 Epilepsy
KiT was inserted, since 2012, in the routine of "‘Ludwig-Maximilians-University Munich, Klinikum"‘
that has a specific unit for monitoring and treating epilepsy patients, where the system’s feasibility
as an epilepsy monitoring tool has already been attested by the medical staff (please see Reference
Letter in Appendix). Besides Kinect data, EEG signals synchronized with our system are also
acquired, enhancing the information provided to the medical staff. KiMA v1 was inserted in the
routine in early February 2014.
In this context, each patient that enters the unit is monitored 24h/7days. The field-of-view of
the Kinect sensor is illustrated in Figure 6.2. Analyzing Figure 6.2, it can be perceived that the
sensor is perpendicular to the horizontal plane. The setup also took into the Kinect limitations.
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Figure 6.2: KiMA v1: Field-of-view of the Epilepsy Room. Typical distances range between
1.9m-2.1m from the sensor to the patient.
Patient’s monitoring using KiT and KiMA were authorized by the hospital’s Ethics Committee,
and all patients signed an informed consent form.
The designed experimental protocol consists in saving the background before initiating the
monitoring of a new patient. The next step consists in whenever an epileptic seizure occurred,
the moment is marked by creating a label. KiT is always acquiring, with a buffer algorithm
continuously running. Whenever a seizure arises, a label is added and is then used as reference to
convert the label into a seizure event in KiMA. Then, using this label as reference, a seizure event
is created and exported in KiMA. Once the event is created, the seizure information is remotely
accessed for the quantification process. The workflow of the process is shown in Figure 6.3.
The data acquired using the KinecTracker includes color and depth data, at 30 fps rate. EEG
signals, synchronized with the Kinect, were also collected at the same time.
Based on the RGB-D data correspondent to seizures, extracted by the physicians using KiMA,
and the associated background depth frame saved in KinecTracker, background subtraction can be
successfully performed over the RGB video. Then, optical flow methods are used with the aim of
detecting and quantifying the movement of the seizure.
6.2.1 Physical Constraints in the Epilepsy Routine
Epileptic seizures are unpredictable and so, whenever a seizure occurs, immediate response is
expected by the physicians which are constantly monitoring the patient. As explained before,
there is a practical setup and protocol meticulously designed to get as much seizure information
as possible. Nevertheless, there are issues related to the fact that this is a real life situation, and so,
most of the times the protocol is not fully respected.
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Figure 6.3: Epilepsy Activity Diagram for KiMA: KiMA is used to segment and export the seizure
Events, which are then made available via a secure FTP server.
There are two major kinds of limitations in the routine: one is related to the lack of robustness
of the skeleton tracking algorithm from the Kinect SDK; the other one is related to the interaction
between the patient physical location and the tasks associated to the normal routine of an hospital
room.
The Kinect SDK 1.5 and K4W SDK v2, as previously explained, allows the 3D tracking of
an individual. In such a complex context as the epilepsy monitoring, accurate estimations of the
body joints using this SDK feature could be done and it would be of extreme valuable importance,
even though with the known limitations of the sensor. Unfortunately, the Kinect SDK Skeleton
Algorithm, in both Kinect v1 and Kinect v2, is not precise enough to provide accurate joints
estimations during a seizure occurrence, and so the chosen setup aims at maximizing the resolution
of the images.
Nevertheless, for still positions, the K4W v2 sensor seems to provide accurate 3D joints esti-
mations, as it can be depicted in Figure 6.6.
K4W v2 sensor was only recently integrated to the system (Late May/June 2014) and, even
with the greater improvement in the skeleton algorithm, it was not able to deal with the presence of
the bed lateral components, and so, whenever a patient has a movement too close to the structure,
the tracking is not efficient enough in deal with such movement (see Figure 6.5). Figure 6.4 and
6.5 show the field-of-view of KiMA v2 installed in an Epilepsy Monitoring Unit: the first-ever
seizure recorded with Kinect v2 sensor.
Even though there have been placed visual markers to set the location of the patient’s bed,
most of the times the bed is dislocated from the optimal field-of-view point of the Kinect sensor.
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Figure 6.4: KiMA v2 Infrared, Body and BodyIndex.
Figure 6.5: KiMA v2 Infrared, Body and Depth.
66 NeuroKinect usage in the Healthcare Context: Practical Examples
Figure 6.6: KiT v2 from LMU Bed: Trial tests to assess the new sensor robustness.
This dislocation happens due to the fact that there is a need to perform imaging methods to the
patients brain (i.e.CT, MRI) and so, the patient needs to be transported. Since this is a routine
healthcare environment, when the patient returns to the room, it might not always be in the target
area.
Besides the dislocation of the bed, often the background frame is not saved. This issue is
critical hence background subtraction of the patient is known as being one of the first methods to
be applied when performing human activity motion analysis. When a seizure arises, the physician
enters the room to better understand what is going on with the patient, and to help in case of
extreme movement acuities. Physicians try to perform a set of activities with the patients to be
able to identify whether the patient is already responsive and can perform demanded tasks, such
as following the path of a pen. The presence of the physician can sometimes interfere with the
field-of-view of the sensor, which contribution would be easily eliminated by the background
subtraction algorithm. Nonetheless, this problem was overcome by performing bed subtraction,
which is explained in the following section.
6.2.2 Bed Subtraction Algorithm
The first frame of each exported event is used to segment the bed. This segmentation is purely
based on the depth information. The first important stage of the process begins with the pre-
processing, where the depth values are filtered to remove noise and also to segment the bed be-
tween known ranges. Depending on the dislocation of the bed from the optimal field-of-view
zone, the depth estimations of the bed range between 1300mm - 2100mm. Using the SDK 1.5,
each per-pixel depth value is converted to an RGB value in order to create the depth frame, just
like in Figure 6.7.
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Figure 6.7: Seizure first depth frame.
At this stage, a seed point, thought to be as belonging to the bed, is provided by the user. Based
on the intensity-pixel transitions between the initial seed point and the eight neighbors, a region
growing algorithm is implemented, where a point is regarded as belonging to the bed if its pixel
intensity is within a threshold.
Once the region growing process is completed, the final step consists in matching the color
frame to the depth frame. There is a need to do that since both stream sources physical location in
the sensor are in different locations (see figure 3.11) and so the two streams need to be re-aligned.
The realignment is automatically performed when using the Kinect SDK online, but at this stage,
this shift was done using the results in a previous study H [2013].
Very briefly, the aim of the study was to evaluate the misalignment between the depth and
color frame of the two streams. To evaluate this misalignment, a script in MATLAB was created.
The procedure is shown in figure 6.8, where the user has already chosen several points, one in the
mask and another on in the color image, which is where the user believes the mask should be.
Once the labeling of the image points between the two streams was completed, mathematical
analysis was done and, two formulas were designed to match the frames:
newX(i, j) = oldX(i, j)+∆X ∗ (oldX(i, j)
imageWidth
; (6.1)
newY (i, j) = oldY (i, j)−∆Y (6.2)
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Figure 6.8: Study to evaluate the difference between mask and color image using MATLAB H
[2013].
where, ∆X and ∆Y are the mean variation values calculated. Figure 6.9 presents the relation
obtained between the mean variation of the square root distance for each par of points versus the
depth in each frame of the movement.
Based on the obtained results, the bed mask image is shifted in a ∆X and ∆Y proportion and is
then applied to all color frames of the event. One example of a successfully subtracted bed mask is
shown in Figure 6.10. Notice that some small black dots arise in the image, inside the bed, which
represent noisy depth estimations that are then easily eliminated in Matlab.
The workflow of the procedure is shown in Figure 6.11.
6.2.3 Optical Flow Approach
Once bed subtraction is performed, optical flow methods are used for the movement detection
and tracking process. Optical flow, as stated before, is the term used to indicate the velocity field
generated by the relative motion between an object and the camera in a frame sequence. Since
Figure 6.9: Mean Variation of the Square Root Distance vs Depth of each frame of the training
image set.
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Figure 6.10: Result of Bed Subtraction over the first frame, after alignment between color and
depth.
the epileptic movements are mostly unpredictable and uncoordinated, by using the optical flow
approach, estimations of which body parts are moving can be achieved.
For this purpose, from the wide range of optical flow algorithms available and already imple-
mented, the choice was to use the Horn-Schunk method. The reasons for this choice were based
on the fact that the state-of-art approaches, namely Karayiannis and Tao [2003] Karayiannis et al.
[2005a] Karayiannis et al. [2005b], to epilepsy movement quantification also used this method.
Furthermore, the Horn-Schunk algorithm is implemented in Matlab 1, within the Computer Vision
Toolbox, referred as vision.OpticalFlow System object. The algorithm provides us with accurate
estimations of the movement boundaries and so, efficient tracking based on that information can
be performed.
Briefly, the Horn-Schunk method, by assuming that the optical flow is smooth over the entire
image, computes an estimate of the velocity field, that minimizes this equation:
E =
∫ ∫
(Ixu+ Iyv+ It)2dxdy+α
∫ ∫
(
∂u
∂x
2
+
∂u
∂y
2
+
∂v
∂x
2
+
∂v
∂y
2
)dxdy (6.3)
1Mathworks http://www.mathworks.com/
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Figure 6.11: UML Activity Diagram of the Bed Subtraction Algorithm.
where α is the smoothness term of the velocity field,
∂u
∂x
and
∂u
∂y
are the spatial derivatives of the optical velocity component u. The α regularization parameter
controls the strength of the smoothness constraint and is usually selected heuristically. The Horn-
Schunck method minimizes the previous equation to obtain the velocity field, [u v], for each pixel
in the image, which is given by the following equations:
uk+1x,y = u
−k
x,y −
Ix[Ixu−kx,y + Iyv−kx,y + It ]
α2+ I2x + I2y
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vk+1x,y = v
−k
x,y −
Iy[Ixu−kx,y + Iyv−kx,y + It ]
α2+ I2x + I2y
where
[ukx,yv
k
x,y] is the velocity estimate for the pixel at (x,y) and [u
−k
x,yv
−k
x,y ]
is the neighborhood average of [ukx,yv
k
x,y]KarayiannisandTao [2003].
Matlab implementation has several properties that can be changed, depending on the aimed
task. In order to gain more sensitivity with the algorithm, the Horn-Schunk method, besides the
Matlab implementation, was manually implemented based on the work of Kesrarat and Patanavijit
[2011]. Then, a physical test using a golf-ball and the Kinect sensor XBOX 360 was performed.
The aim of this physical test was to clearly assess the behavior of both algorithms. The test
consisted in video-recording (color and depth streams) the movement of the ball along an inclined
plan, and then track and quantify the ball movement using both Optical Flow algorithms. The
algorithm designed for the golf-ball tracking consisted in comparing, frame-by-frame, the optical
flow lines within an initial mask, provided by the user. Then, using as reference the optical flow
lines drawn in each frame, the mask was continuously shifted based on the differences between
the mask centroids. The setup used can be seen in Figure 6.12.
Figure 6.12: Schematic Representation of the conducted trial to perceive and validate the perfor-
mance of the Optical Flow Algorithms.
Beforehand, the expected result was predicted to be: positive velocities in terms of Vy (velocity
along the Y axis) and± zero velocity along Vx, since the ball was dropped on the top of the inclined
plane, where the ball is only under the gravity force, being zero its initial velocity and acceleration,
and the movement would be almost linear. Along the incline plane, conservation of mechanical
energy was considered. Three different movements were recorded, with different heights so that
the velocities achieved by the ball were different. The results of the tracking are shown in table 6.1.
Table 6.1: Characteristics of the ball movement in terms of initial velocity, acceleration and the
angle of the incline plane
h (cm) v0 (m/s) a (m/s2) α (o)
2 0.632 0.069 3.95
5 1 0.174 10
7 1.14 0.242 14
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Figure 6.13 presents the 2D movement of the ball, in terms of the X and Y coordinates. Ana-
lyzing it, it can be perceived that the movement was not totally uniform as anticipated.
Figure 6.13: Tracings of the 2D golf-ball movement in terms of the X and Y coordinates for the
slowest movement.
Figure 6.14 presents the comparison between the real depth value measured by the Kinect
sensor and the theoretical value calculated for the position of the ball. The formula used was:
3Dposition = x0+ v0 ∗ t−0.5∗a∗ t2 (6.4)
where x0 is the initial position, v0 the initial velocity, a the acceleration and t the time interval.
We can clearly see that even though there were some noisy estimations, the depth values
obtained are pretty accurante when compared to the theoretical values.
Table 6.2: Results obtained on the Optical Flow algorithms: Maximum and Minimum Optical
Flow velocities values of the ball, for the two algorithms.
OF_Matlab OF_Hugo
Vx Vy Vx Vy
H (cm) Max Min Max Min Max Min Max Min
2 0.094 -0.080 0.1914 0.053 1.712 -1.699 5.676 -0.992
5 0.097 -0.097 0.1824 -0.017 1.969 -1.802 4.856 -1.142
7 0.096 -0.085 0.1622 -0.023 1.409 -1.981 5.8435 -1.682
Analyzing the results obtained, several conclusions can be drawn. Firstly, both algorithms
quantified the ball in the expected way, even though the values along Vx were expected to be
considerably lower. Secondly, the output values from the Matlab implementation seem to be
normalized between 0 and 1, which is another important conclusion. Besides that, a movement
with 0.6 m/s initial velocity was quantified with similar optical flow speed as a movement of 1
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Figure 6.14: Tracings of the 3D golf-ball movement in terms of the real depth value (provided by
the Kinect) and the calculated theoretical one for the slowest movement.
Figure 6.15: Tracings of the 2D golf-ball movement in terms of the Optical flow velocities for the
slowest movement.
m/s, which is another relevant conclusion. This similar quantification is related to errors in the
ball tracking, even though in visual terms, the output video from the ball tracking seems to be
pretty accurate.
In terms of optical flow units, since the results seem to be normalized, an immediate con-
clusion cannot be drawn, not even when relating to the cited article in the Mathworks website.
Nevertheless, there are reasons to believe that the units are ∆pixels/frame. Finally, based in this
study, for the epilepsy movement detection and quantification, the decision was to use the Matlab
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implementation due to the fact that it is more robust and it is not as time-consuming as our own
implementation of the algorithm.
6.2.4 3D Motion Tracking Algorithm based on Optical Flow
Based on the main concept of the algorithm developed for the golf-ball tracking, a more robust
one was design to track movements within seizures.
Prior to the actual tracking, the Optical Flow velocities are calculated, using a certain gain,
being the output value in the form of Horizontal and Vertical Components, which gives us the
velocities vectors in both directions. Besides the OF velocities, the OF lines are drawn in each
frame. The OF lines are dependent of the gain used for calculating the OF, and so, in order to track
a movement with the best accuracy possible, this gain should be as high as necessary to draw the
lines on the boundaries of the movement, just like in Figure 6.16. Besides the OF, the Depth data
extracted from the Kinect sensor is also used.
The depth estimations, even though with the previously explained problem of misalignment,
provides us with the "‘ground-truth"’ of the physical position of the aimed ROI and so, that same
information is used to automatically correct the algorithm.
The tracking process is initiated with the creation of a mask over the aimed ROI. An initial
seed point is also set by the user. In each frame, the lines within the mask are targeted. If there are
no lines, it may mean one of two things: 1) the OF gain used is unable to detect the boundaries of
the movement; 2) there is no movement. Assuming that the user selected a proper gain, if no lines
are find within the mask, it is assumed that there is no optical flow velocity and so, in the next
frame, the same mask is used.
In case there are OF lines, it means that movement was detected. The typical state-of-art
approach uses the maximum velocity in the area to quantify the movement. For the tracking, we
measure which are the "%" highest velocities and we then calculate the median of this values for
both the Horizontal and Vertical plane. The median was considered after performing the Jarque-
Bera test, which confirmed that the output values obtained did not followed a normal distribution.
Furthermore, using a percentage of the highest velocities enables us to filter the tracking for noise.
The median values are then multiplied by a certain gain to transform them into pixel dimensions.
The original mask is then shifted in the calculated proportion in each direction.
At this stage, a depth criteria is implemented in order to auto-correct the algorithm and also
to avoid tracking errors: if the centroid of the new mask is within a certain depth range when
compared to the previous positions, the new centroid is labeled as acceptable; else, within the
current mask we look for a point of similar depth. If after the auto-correction section, the algorithm
is unable to find the next centroid, the user is requested to draw another ROI. The process is
repeated until all frames are analyzed.
To avoid high-frequency transitions, each time that the algorithm needs to auto-correct himself
and when the user draws another ROI, a spline interpolation is performed over the calculated
centroids to smooth the movement. In the end, the Savitzky-Golay FIR smoothing filter is also
applied to the movement sequence.
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Figure 6.16: Epilepsy Seizure Frame, with bed subtraction performed and OF lines drawn in the
frame. The orange arrow represents the actual lines (which represent the detected movement by
the algorithm) that are intended to be tracked, whereas the red arrow represents the upper body
movement. Note that the original image was rotated 90o for visualization purposes only.
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The schematic of the algorithm is presented in Figure 6.17.
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Figure 6.17: UML Activity Diagram of the designed algorithm.
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6.2.5 Quantification Results
Figure 6.18: KiMA UI: Seizure initial frame.
The proposed semi-automatic approach was applied to an uncoordinated seizure (see fig-
ure 6.18), in order to track the head and both hands movement. This seizure, recorded with Kinect
XBOX 360 at 30 fps, induced uncoordinated movement in both three body parts, with a duration
of twelve seconds (complex motor seizure - hypermotor), and the patient had an IV fluid wire
attached to this right-hand, which was also very close to his head.
An overview of the motion pattern presented in the patient seizure can be depicted in Fig-
ure 6.19.
The IV wire is a constraint that its contribution cannot be eliminated and it is a source of noisy
measurements, since the OF algorithm is extremely sensitive and it detected the wire movement.
Nevertheless, the relative error obtained in the head tracking was low. This error was measured
by comparing the tracked centroids to the manually labeled ones throughout all frames. The mean
relative errors (mean and standard deviation) were:
XCentroid : 1.94±1.14% (6.5)
YCentroid : 8.49±7.32% (6.6)
Comparing our semi-automatic approach, with a state-of-art 2D motion analysis software, Max-
TRAQ 2, not only our approach provides us with 3D information but also the time that it is saved
in the task of manually labeling all centroids in each frame is considerable: as an example, for
2Software Maxtraq http://www.innovision-systems.com/Products/MaxTraq.html
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Figure 6.19: Representation of the motion pattern experienced by the patient during the quantified
seizure.
the head tracking (378 frames), our semi-automatic algorithm took around 45 seconds whereas in
the MaxTRAQ environment, where the user needs to set each centroid manually, it took roughly 3
minutes and 30 seconds. When performing the labeling manually, the user has a much higher con-
trol and confidence over the process. Nevertheless, such task is more demanding for the operator,
in terms of usability and practicability.
Figure 6.20 presents one snapshot of the manual centroids labeling done to compare the two
approaches.
Once the movement tracking is completed, 2D and 3D quantification is performed. It can
quantified in terms of the OF velocities (Magnitude, Horizontal and Vertical); 2D Centroids po-
sition variation; Depth variation; and finally, in terms of the 3D Velocity and Acceleration. From
Figure 6.21 to Figure 6.26, the blue, red and green points in the time axis represent the moments
when the user had to intervene in the tracking process.
The output trajectories of the tracked centroids are showed in Figure 6.21 and Figure 6.22.
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Figure 6.20: MaxTRAQ 2D motion software UI. In the represented frame there is a marker with
the centroid of the head at a certain moment in time. The green line represents the head movement
throughout the frames.
Figure 6.21 shows the motion of the centroid(pixel unit) in x axis direction and Figure 6.22 shows
similar information in the y direction.
Figure 6.21: Tracings of the body motion in X coordinate (anterior-posterior view), non-filtered
and filtered, in function of time with the corresponding body positions.
The optical flow velocities of the tracked centroids are showed in Figure 6.23, Figure 6.24 and
Figure 6.25. Figure 6.23 shows the magnitude velocity(∆Pixels2 unit). Figure 6.24 and Figure 6.25
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Figure 6.22: Tracings of the body motion in Y coordinate (vertical), non-filtered and filtered, in
function of time with the corresponding body positions.
show the horizontal and vertical velocity(∆Pixels unit), respectively.
Figure 6.23: Tracings of the optical flow magnitude velocity in function of time with the corre-
sponding body positions.
The depth values of the tracked centroids are showed in Figure 6.26. Figure 6.26 shows the
depth values (meters unit) non-filtered and filtered, which were obtained by applying a Butterworth
low-pass filter with a cutoff frequency of 6Hz.
Using the depth values and the 2D centroids, it is possible to convert this 2D information
[x(px), y(px), z(m)] to 3D [x(m), y(m), z(m)] in meters unit. This conversion was performed after
mapping the 2D tracked RGB centroids to 2D - Depth centroids, and then convert the 2D-Depth
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Figure 6.24: Tracings of the optical flow magnitude horizontal velocity in function of time with
the corresponding body positions.
Figure 6.25: Tracings of the optical flow vertical velocity in function of time with the correspond-
ing body positions.
raw values into the third dimension. The formulas to make such a conversion are available online3.
The 3D velocity and acceleration were calculated using:
3Dvelocity =
√
v2x + v2y + v2z ≈
√
∆x2+∆y2+∆z2
∆t2
(6.7)
3Dacceleration =
√
a2x +a2y +a2z ≈
√
∆vx2+∆vy2+∆vz2
∆t2
(6.8)
3Kinect Calibration: converting 2D depth to 3D coordinate space http://burrus.name/index.php/Research/
KinectCalibration
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Figure 6.26: Tracings of the depth values, non-filtered and filtered, in function of time with the
corresponding body positions.
The velocity of the tracked centroids are showed in Figure 6.27. Figure 6.27 shows the velocity
values (meters/s), using the filtered centroids and depth data.
Figure 6.27: Tracings of the velocity values filtered, in function of time with the corresponding
body positions.
Figure 6.28 shows the difference between the velocities using the non-filtered and the filtered
data, for the Head ROI.
Finally, Figure 6.29 shows the acceleration of the tracked centroids (meters/s2) using the
filtered data.
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Figure 6.28: Tracings of the velocity values non-filtered and filtered of the Head, in function of
time.
Figure 6.29: Tracings of the acceleration values filtered, in function of time with the corresponding
body positions.
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6.2.6 KiSA: Kinect Seizure Analyzer
A Matlab GUI, named KiSA (Kinect Seizure Analyzer), was developed so that the tracking and
quantification process previously reported can be performed in the most user-friendly and intuitive
way. KiSA is a motion quantification software that is dependent of KiT and KiMA: KiT saves the
seizure information and then, using KiMA, the MOI is segmented and exported to be analyzed in
KiSA.
Figure 6.30: KiSA Use-Case Diagram
.
The main requirements defined for KiSA are the following:
1. Offline visualization of seizures data previously segmented and export data from KiMA
(color images, depth file);
2. Video manipulation (play, pause, rewind, next frame, stop);
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3. Human body parts tracking based on a semi-automatic approach;
4. Quantification and Visualization of the tracking data.
KiSA’s main window UI includes a menu and tool bars, visualization area (with primary and
secondary sources), Options and Analysis panel. In addition, there are regular video manipulation
options (play, pause, stop, rewind, previous and next frames). There is also a video progression
bar, corresponding to the slider located above the manipulation buttons. The current timestamp,
the elapsed time and the current frame number are shown on the right side above the slider.
When data regarding a seizure is loaded into the software, the optical-flow is immediately
calculated and the two sources of information are instantly available in the two sources. This
allows for an immediate visual inspection and comparison of the original RGB information and
the Optical Flow analysis. This feature allows requirement 1 and 2. Furthermore, there is an
Options panel where several parameters can be adjusted. Also, in the main window, there is a
button which initiates the tracking process, addressing requirement 3. Finally, when the tracking
process is completed, another window is displayed where the movement quantification results
(showed before) are presented, addressing requirement 4.
In the analysis window, the user can immediately load the output video, which is saved once
the tracking process is performed. In addition, there is one 2D plot, that addresses the variables
calculated before, and one 3D plot for the visualization of the 3D centroids position. Finally, there
is a statistics panel for each variable.
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Figure 6.31: KiSA activity diagram.
.
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Figure 6.32: Main Window UI of KiSA application, including the display of color and optical flow
images. In yellow: the menu bar; In red: the current timestamp; In orange: the elapsed time; In
blue: the current frame number; In green: the video manipulation buttons.
Figure 6.33: UI of KiSA Parameters.
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Figure 6.34: UI of KiSA Analysis. Representation of the depth tracing and the 3D position, as
well as the statistics of the depth Head variation.
6.3 Other usages of NeuroKinect 89
6.3 Other usages of NeuroKinect
Besides the collaborations in Parkinson’s and Epilepsy, since the KiMA development, collabora-
tions with other neurological movement disorders arose.
6.3.1 Familial Amyloid Polyneuropathy (FAP) and Movement Rehabilitation Strate-
gies in Patients that suffered Strokes
Familial Amyloid Polyneuropathy (FAP) is a rare neurologic disease caused by an autosomal
dominant genetic mutation that specially affects the peripheral nervous system. It is a highly
disabling multisystemic disorder with variable onset and penetrance worldwide.
In Portugal, the largest known affected population, transthyretin (TTR) FAP is the most com-
mon type of FAP and it is typically characterized by a nerve length-dependent symmetric polyneu-
ropathy that starts in the feet with loss of temperature and pain sensations and is associated to life-
threatening autonomic dysfunction, leading to cachexia and death within 10 years, on average.
The motor disorder progresses from difficulty ambulating until the need for walking assistance,
wheelchair and total motor disability in latter stages. The gait pattern of TTR-FAP patients is
described as similar to the gait pattern of diabetic neuropathy, called steppage (pendent feet and
bent knee), but it has never been quantified.
This project aims at describing and quantifying the motor impairment of this population, fo-
cusing on gait. The goal is to describe in detail the gait pattern of TTR-FAP patients and to detect
inter and intra-individual parameters for the development of a tool to support earlier clinical di-
agnose using the KinectTM v.2.0 from Microsoft. At this moment, the gait of five patients and
five controls were already acquired using KiT, and results on this quantification are being at the
moment processed using KiMA for gait cycles partition and then Matlab for the mathematical
analysis.
In terms of the interaction with the software, the person responsible for the project provided us
with this feedback: "‘The KinecTracker and KiMA (Kinect Motion Analyzer) were the applica-
tions used for data collection and analysis of the gait pattern alterations of Transthyretin Familial
Amyloid Polyneuropathy (TTR-FAP) patients and mutation carriers. Both applications are fast
and very intuitive.
On site, it was easy to get everything ready and perform the planned set up at the Neurophys-
iology Clinical Service of Hospital Santo Antonio, Porto, Portugal. Subjects reacted very well to
the paraphernalia and were curious regarding skeleton tracking. During data collection it is truly
important to be able to assess skeleton tracking in loco and quickly optimize the setup; moreover,
during data processing, it is very useful to be able to mark moments of interest with labels and
events to better compute measures of interest for specific research.
These applications have great potential on assessing movement alterations at the clinical yard
without wasting clinicians and patients’ time and without the need of special environment. We
will keep using this software and helping to improve its performance. "‘.
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Besides supporting the Familial Amyloid Polyneuropathy (FAP) project, both software’s are
also being used to support the influence of postural control in the mid phase of gait support in
patients that suffered strokes.
The goal is to objectively assess the influence of the postural control in the gait of the patients,
undergoing rehabilitation strategies. Using KiT and KiMA, the treatment strategies, as well as
the progress of the patient, will be evaluated in a 6 weeks window, using the recent KinectTM
v.2.0 from Microsoft. At the moment, the two moments were already acquired and the gait cycles
partitions were already performed using KiMA. Currently, the mathematical analysis is being done
using Matlab and MokkA.
In terms of the interaction with the software, the person responsible for the project provided
us with this feedback:"’ The system is quite interesting and has as main advantage the fact of
being portable, enabling this way taking it to the Healthcare context, namely ADE Rehabilitation
Clinic, Famalicão, Portugal. It is also very easy to get everything ready and perform the planned
set up. The majority of the patients thought the idea quite interesting and even shown curiosity
in understanding the processes being performed. In terms of the software, KiMA is user-friendly
and, with its continuous development, it will be very useful in the analysis of the data collected
with the sensor."’
Chapter 7
Discussion and Future Work
The Microsoft Kinect is certainly a remarkable piece of technology that truly is one of a kind.
Despite its original intention being far different than ending up in scientific research, it is a fact
that the inherent specifications and characteristics of the device makes it very attractive to several
fields of research. The device has several limitations, but can be used as a low-cost effective
solution for motion capture. The main advantage of the RGB-D sensors reviewed is the fact that
they all are a novel motion analysis tool which allows markerless tracking, making them suitable
for our quest in implementing a low-cost markerless video-system for movement tracking and
analysis.
Kinect sensor breakthrough functionalities, with the skeletal joints in addition to the RGB
and depth (plus infrared and bodyindex in the K4W v2) images, have potentialized the human
activity analysis. The body joints representation provided by the skeletal tracking have tremendous
importance and relevance, since that body parts are very difficult to be obtained from the normal
RGB video data.
This representation simplifies the human tracking and activity recognition, and since the 3D
skeleton poses are viewpoint and appearance invariant, it allows for more robust pose estimation
and action recognition. The majorities of the works using the Kinect sensor take advantage of the
skeletal joints and design models on top of them. Nevertheless, some issues arise when doing this:
detected body joints tend to be noisy and unreliable in some situations (occluded scenes).
NeuroKinect embraces the majority of the Kinect SDK features in a package of software that,
since its first official release in February 2014, has been continuously improved and has already
been used in multiple healthcare scenarios.
Prior to the release of the March release of K4W v2, there was (as far as known) none available
software that allowed not only gathering the streams of information acquired but also the manipu-
lation of the acquired data in a user-friendly UI like ours. KiMA answers this need, even though
it is oriented to a certain file structure.
NeuroKinect is more than just a software package: it is a markerless RGB-D video capturing
system that has the possibility of being used barely everywhere; in less than ten minutes, the soft-
ware (KiT) is already acquiring and the analysis in KiMA, if intended, can start immediately after
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the acquisition of the first patient. In addition, by immediately reviewing the acquired data, on-
the-spot changes to the planned setup can be performed in order to maximize the data acquisition.
NeuroKinect strengths rely in its portability and in being markerless, which make it suitable
for the healthcare environment. The K4W v2 sensor, when compared to the previous one, is un-
doubtedly more robust and overall much better than the previous one. With the two new available
streams, the amount of information acquired is critical (about 4GB/min for Kinect v1, 12 GB/min
for Kinect v2) when acquiring all available streams.
At the moment, KiMA only allows a primary segmentation of the collected data, and the anal-
ysis is performed elsewhere, mainly in C# and Matlab. For that purpose, pipelines were created
that allow using the raw information acquired with the sensor in Matlab. The critical information
are the depth raw values, since that, using KiMA, the color, depth, bodyindex and infrared im-
ages can be quickly created. Using the raw depth values enhances any kind of image processing
intended to be performed afterward.
Besides KiMA development, interesting work was developed in multiple healthcare scenarios,
as explained before. The focus are neurological diseases with movements impairments (Neuro
from Neurological, Kinect from movement analysis).
Gait impairments in Parkinson’s disease are known to evolve with the progression of the dis-
ease. The importance of a correct diagnosis is then critical: the sooner the problem is detected,
the faster it can be handled. This is where our method enters, with a low-cost markerless video
system that aims at being able to provide important and relevant information to the clinicians in
order to assess the disease and its progress throughout time.
An interesting number of gait acquisitions were performed over the last year, in São João
University Hospital (Porto, Portugal), from which resulted three publications, one international
and two national. Even though the national publications are important, the international paper,
submitted for the most credited Biomedical Engineering Conference in the world, is a milestone
that validates our approach to movement quantification using the Kinect sensor. At this moment,
on-going work is being done, using now both Kinect XBOX 360 and also K4W for the patients gait
acquisition, and KiMA for the gait cycles partition and also for the on-the-spot visual inspection
of the patients gait.
With this work, we have shown that our low-cost portable system can be easily mounted in
any hospital environment for evaluating patients’ gait/updrs and, besides that, it was very well
accepted by the patients, since it is markerless and non-intrusive. On average, a normal recording
of a patients gait, with the stimulator ON and OFF, takes around five minutes. Besides PD, the
on-going collaborations using the NeuroKinect system will also show the superior ability in the
proposed approach in being used in multiple scenarios, with the outstanding fact that FAP gait has
never been quantified before.
So far, all this projects were based in the acquired skeleton data and the analysis and quan-
tification process is designed over that information. In the Epilepsy disease, the skeleton data is
not accurate enough to perform a quantification process and so, the proposed method is based on
image processing. KiMA, at the moment, only provides the physicians the possibility of review-
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ing the seizure and that visual analysis allows only a rough estimate of the motion pattern of the
seizure.
From the clinicians perspective, uncoordinated seizure motion pattern of the patient’s body is
considered as a valuable evidence in the identification not only of the presence of a seizure but also
its source. Using the optical-flow as a reference for the motion pattern, and based on the physical
test with a golf-ball, a semi-automatic approach was designed with interesting results.
The algorithm is highly dependent of accurate depth estimations and since that the two streams
are misaligned, the tracking task is extremely difficult. Nevertheless, with the manual shift intro-
duced, the results are quite interesting since that, for the head movement, the user only had to
intervene in the process five times throughout the total number of frames(378). In terms of the
efficiency of the proposed approach, we have compared our analysis with the one that would be
done by using a state-of-art 2D motion analysis software, Maxtraq, and the results were significant:
not only our approach saves physicians critical time but also provides them with 3D information,
which using MaxTraq would require the use of at least 3 RGB cameras.
Efforts are currently being done so that this color-depth mapping (can only be performed us-
ing the sensor online) can be saved to file and used to have 100% certainties that the two streams
are correctly aligned. Once this information is available, the robustness of this approach is highly
enhanced and can definitely be used for markerless tracking and quantification of uncoordinated
seizure movements. Also, the algorithm designed needs validation in other seizures information
since that it was only applied for this one seizure. Comparing the results obtained for the three
movements with the video analysis, even though there might be some noisy measurements, es-
pecially in both hands tracking, the overall values obtained are accordant with the movement
characteristics.
With the development of KiSA, physicians can now perform qualitative as well as quantitative
movement analysis using KiT+KiMA+KiSA. As a proof of concept, the decision then was to
design a similar KiMA UI in Matlab (to ease the interaction of the familiarized physicians to
KiMA for KiSA) but with different requirements, as it was explained before.
KiSA is a prototype which, as well as the proposed semi-automatic approach, will be contin-
uously developed, with the hope of becoming an important tool in the epilepsy scenario. The idea
is to integrate the developed approach into a plug-in for KiMA.
With the recent introduction of Kinect v2 in the Epilepsy Monitoring Unit, seizures can now be
tracked during day and night by using the infrared stream. To our knowledge, there is no similar
system like ours, built-in inside an hospital routine. Nevertheless, using the infrared and depth
information from Kinect v2 to track and quantify, without using color (becomes too expensive in
terms of amount of information gathered), will definitely be a possibility to consider and explore
in a very short time.
Very recently, nonprofit EIC BBK-Dravet Syndrome Foundation developed the "‘Night Seizure
Monitor"’ 1, that detects seizures patterns during kids sleep, using the Kinect for Windows v2 sen-
1Microsoft Uses Kinect to Create Epilepsy Night Seizure Monitor http://news.softpedia.com/news/
Microsoft-Uses-Kinect-to-Create-Epilepsy-Night-Seizure-Monitor-447470.shtml
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sor, which proves that what is being done at the moment is extremely valuable and we hope that
accurate scientific research can result from this straight cooperation between the university and the
hospitals.
KiMA, which was developed inside a multi-disciplinary environment (Biomedical, Informat-
ics and Electro engineering), has already proven that it has the possibility of becoming an impor-
tant tool in movement analysis.
Future work includes transforming our current file structure to make it compatible for *.C3D
files, as well as transforming KiMA from its current role (primary source of data segmentation) to
a movement analysis quantification software, with the integration of KiSA features and also with
features important for gait analysis, such as cadence, speed or angles between joints.
KiMA efforts were not only appreciated and validated from the physicians, but they were as
well accepted by the scientific community. In addition, KiMA was also presented in a Portuguese
Biomedical Student Conference and most importantly, it was presented in the Kinect for Windows
v2 Developer Program Preview Conference in Berlin, Germany (April 2014). The feedback from
the Microsoft engineers was absolutely overwhelming and it motivate us to work even further to
continue the development of the software.
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In order to use the *.dll file, .NET framework needs to be installed in the computer. The steps
for installation of the pipeline are as follow:
1. Run Windows Command Line (i.e. CMD) as Administrator;
2. Copy the .NET Framework folder path to the CMD window, command:
cd C:\Windows\Microsoft.NET\Framework64\setminus v4.??????
3. Copy "‘KinectforMatlab.cs"’ to the .NET Framework folder;
4. Compile the KinectforMatlab.cs file to a *.dll, command:
\csc /t:library KinectforMatlab.cs
5. Register the KinectforMatlab.cs Active X control, command:
regasm KinectforMatlab.dll /tlb /codebase
The procedure is showed in figure A.1, where the final message states that the pipeline was
successfully compiled.
Figure A.1: KinectforMatlab.dll Pipeline Procedure
.
Once the source code pipeline is compiled, in order to use it on Matlab, the following com-
mands should be used: firstly, load the .NET library. Then, for example, to access the depth
information of a *.kdpt (depth) file, the following command should be used:
depthValue = net.depthKinectvOne(′ f ilename′,′ kd pt ′,′ pixelY ′,′ pixelX ,′ f rameNumber′);
(A.1)
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Re: Kinect for Windows Developer Preview Program 
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This letter confirms that Hugo Choupina (University Porto, Portugal) took part in the Kinect for Windows 
24-hour hack-a-thon in Berlin, Germany April 11 – 12, 2014. This event was hosted by the Microsoft 
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and researchers worldwide the ability to participate in the beta test of the Kinect for Windows v2 sensor 
and software development kit (SDK). 
 
Sincerely, 
Heather Mitchell 
Business Development and Strategy Manager 
Microsoft Kinect for Windows 
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To!whom!it!may!concern:!
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The!KinecTracker!(KiT)!and!Kinect!Motion!Analyzer!(KiMA)!software!developed!at!pro=
fessor!João!Paulo!Cunha’s!lab,!are!being!used!at!the!Epilepsy!Monitoring!Unit!of!the!
University!of!Munich!by!our!technicians!and!neurophysiologists.!Quantification!of!
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Parkinson’s Disease Assessment Based on Gait Analysis Using an
Innovative RGB-D Camera System
Ana Patrı´cia Rocha, Student Member, IEEE, EMBS, Hugo Choupina, Jose´ Maria Fernandes,
Maria Jose´ Rosas, Rui Vaz, Joa˜o Paulo Silva Cunha, Senior Member, IEEE, EMBS
Abstract— Movement-related diseases, such as Parkinson’s
disease (PD), progressively affect the motor function, many
times leading to severe motor impairment and dramatic loss of
the patients’ quality of life. Human motion analysis techniques
can be very useful to support clinical assessment of this type
of diseases. In this contribution, we present a RGB-D camera
(Microsoft Kinect) system and its evaluation for PD assessment.
Based on skeleton data extracted from the gait of three PD
patients treated with deep brain stimulation and three control
subjects, several gait parameters were computed and analyzed,
with the aim of discriminating between non-PD and PD subjects,
as well as between two PD states (stimulator ON and OFF). We
verified that among the several quantitative gait parameters, the
variance of the center shoulder velocity presented the highest
discriminative power to distinguish between non-PD, PD ON
and PD OFF states (p = 0.004). Furthermore, we have shown
that our low-cost portable system can be easily mounted in any
hospital environment for evaluating patients’ gait. These results
demonstrate the potential of using a RGB-D camera as a PD
assessment tool.
I. INTRODUCTION
Parkinson’s disease (PD) is an idiopathic neurodegenerative
disease, which results from the death of brain cells that
produce dopamine [1]. The lack of dopamine typically leads
to characteristic motor symptoms, such as bradykinesia (i.e.
slowness of movement), shuffling gait, and freezing of gait
(i.e. sudden and brief motor blocks).
An estimated seven to ten million individuals worldwide
have PD [2]. This number is expected to rise significantly
in the future [3], with 60,000 new cases being currently
reported every year only in the U.S. [2]. Even though
PD has presently no cure, there is available treatment that
can improve functional capacity. A possible treatment is
deep brain stimulation (DBS), which consists in implanting
stimulating electrodes in the brain, and a pulse generator.
To provide the best possible treatment, both an early
diagnosis and regular evaluations are essential. The diagnosis
of PD is currently based mainly on clinical criteria [1]. During
This work was supported by EU funds through COMPETE and by national
funds through the Portuguese Science Foundation (FCT) within the projects
PTDC/EEI-ELC/2760/2012 and PTDC/NEU-SCC/0767/2012.
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PD follow-up, the monitoring of the disease’s progression
and treatment outcome is usually based on a rating scale,
such as the Unified Parkinson Disease Rating Scale (UPDRS)
[4]. In both cases, the assessment typically includes visual
examination of motor symptoms by physicians, which tends
to be rather subjective. So, the quantification of motor signs
can be very useful to enhance both PD diagnosis and follow-
up [5], [6], and possibly lead to an improvement of treatment
and overall life quality of PD patients.
Gait analysis in PD, using motion or vision sensors, has
been studied by various authors [5], [6], [7]. In [6], the authors
proposed a PD monitoring tool, based on six accelerometers
and one gyroscope. Based on sensor data collected from PD
patients, they extracted parameters that can be useful for
distinguishing between on and off states.
A vision-based system for PD assessment (distinction
between non-PD, PD drug on and PD drug off states) was
proposed in [5]. The authors recorded videos of PD patients
and control subjects while walking. A minimum distance
classifier was then built, based on features resulting from gait
analysis, which achieved an accuracy of 80.5%.
Recently, the Microsoft KinectTM has been used for gait
analysis [7], [8], [9]. The Kinect is a low-cost, portable RGB-
D (Red, Green, Blue, Depth) camera [10] that provides color
and depth image sequences, as well as skeleton data resulting
from 3D tracking. This camera has the added advantage of
being less intrusive than marker-based sensors. Moreover,
when compared with RGB cameras, it allows motion analysis
in less controlled environments, due to the use of a depth
sensor based on infrared light, without losing accuracy [9].
A gait analysis system that uses a Kinect was developed
in [8]. Regression models were built based on skeleton data,
and ground truth measures (using in-shoe pressure sensors
and a gyroscope), which were collected from subjects while
walking. The obtained models were able to estimate stride
duration and arm angular velocity, with an average absolute
error in the range between 32 and 71 milliseconds, and 14
and 22 degrees/second, respectively.
Regarding PD, the validity of the Kinect for movement
measurement in PD patients was recently explored in [7].
When compared with a Vicon system, the sensor was able to
accurately measure timing and gross spatial characteristics
of clinically relevant movements, validating its use for gait
analysis in the health care context, namely in PD.
Considering the potential of RGB-D camera systems to
constitute a low-cost and portable solution for assessing
movement-related diseases, we explore in this contribution
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the possibility of using such a system as a PD assessment
tool. We carried out an evaluation of both PD patients and
control subjects, during a walking task, which consisted in
the extraction of several gait parameters from skeleton data
acquired by using our KinecTracker application. Moreover,
the usefulness of those parameters for supporting both PD
diagnosis and follow-up was studied.
II. MATERIALS AND METHODS
An experimental protocol was carried out in a room at
Sa˜o Joa˜o University Hospital (Porto, Portugal), with the
participation of three PD patients (P1, P2 and P3) and three
control subjects (C1, C2 and C3). Each PD patient had an
implanted DBS stimulator, and performed the experiment
twice: with the stimulator on (STIM ON); and a few minutes
after turning off the stimulator (STIM OFF). Each control
subject performed the experiment only once.
The protocol included the use of the KinecTracker ap-
plication, developed in C# by our group using the Kinect
Software Development Kit v1.5 [11], to acquire skeleton
data (at a 30 fps rate) from PD patients and control subjects,
while they were walking. The walking trajectory of four
meters is illustrated by an arrowed dashed line in Fig. 1. This
figure also includes the relevant distances, as well as the
Kinect height and tilting angle in relation to the horizontal
plane (perpendicular to the gravity force). The chosen setup
took into account the Kinect limitations [12], and aimed at
maximizing the actual tracking area, which is represented by
the grey rectangle in Fig. 1.
The demographics of the control subjects and PD patients
are presented in Table I. For the PD patients, disease-related
details are shown in Table II, including the number of months
since DBS surgery, and the UPDRS scores for the motor
examination section and the specific gait item [4]. The study
was authorized by the hospital’s Ethics Committee, and all
subjects signed an informed consent form.
Each acquired frame data corresponds to a skeleton of
twenty joints, illustrated in Fig. 2 (a). Fig. 2 (b) shows
an example of depth and skeleton data, as displayed in
KinecTracker (user interface shown in Fig. 3). Each joint
corresponds to a 3D position, considering the coordinate
system associated with the Kinect [12] (depicted in Fig. 1).
The data acquired within the tracking area were firstly
manually selected, and then partitioned into gait cycles, based
on depth data acquired at the same time as the skeleton data.
K
inect
1.90 m1.36 m
1.255 m
Height = 1.38 m
Tilting angle = -160
z
x
y
Fig. 1. Experimental setup used for data acquisition, including the coordinate
system associated with the Kinect.
TABLE I
SUBJECTS’ CHARACTERIZATION (AVERAGE AND [MINIMUM, MAXIMUM]
VALUES FOR AGE, WEIGHT, AND HEIGHT).
Control subjects PD patients
Gender (male/female) 2/1 2/1
Age 49 [46, 54] 53.7 [47, 59]
Height (m) 1.65 [1.58, 1.72] 1.68 [1.59, 1.8]
Weight (kg) 83.3 [54, 118] 82.7 [78, 90]
TABLE II
PARKINSON’S DISEASE PATIENTS’ CHARACTERIZATION REGARDING DBS
AND UPDRS SCORES.
PD patient Months afterDBS surgery
UPDRS IIIa (gaitb)
STIM ON STIM OFF
P1 6 13 (1) 31 (1)
P2 1.5 7 (1) 26 (1)
P3 10 11 (0) 42 (2)
a UPDRS motor score (part III). The maximum score is 108. [4]
b UPDRS gait sub-score (item 29). Score ranges between 0
(normal) and 4 (cannot walk). [4]
We considered that a gait cycle begins when the left/right
foot initiates contact with the ground (ICL/R), and ends when
the same foot initiates again contact with the ground. In
the data analysis presented below, we used only the data
corresponding to the portion of the walking sequence where
the subject is walking towards the camera, since we verified
that the remaining data were much noisier.
As indicated in Fig. 1, the Kinect was tilted by rotating
−16◦ around its x-axis, with the aim of obtaining the optimum
field of view. In order to simplify comparison between results
obtained with different angles, and facilitate interpretation
of results, the joints’ 3D positions were converted into a
coordinate system corresponding to a non-tilted camera (angle
of 0◦).
Based on the resulting data we created two different
datasets: unfiltered and filtered. The filtered dataset was
(a) (b)
Fig. 2. Skeleton joints provided by the Kinect (a), and depth and skeleton
data as displayed in the KinecTracker application (b).
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Fig. 3. User interface of the KinecTracker application.
obtained by using a first order low-pass Butterworth filter,
with a cutoff frequency of 5 Hz, over the unfiltered data. For
both datasets, the following 34 measures were computed, for
each frame of each left/right gait cycle:
• Velocity of the left/right foot, ankle, knee and hip,
right/left hand, wrist, elbow and shoulder, central hip
and shoulder, spine, and head, using (1);
• Acceleration of the left/right foot, ankle, knee and hip,
right/left hand, wrist, elbow and shoulder, central hip
and shoulder, spine, and head, using (2);
• Distance between feet, ankles, knees, hands, wrists, and
elbows, using (3);
• Angle at left/right knee (defined by hip, knee and ankle
joints), right/left elbow (defined by wrist, elbow and
shoulder joints), center shoulder (defined by spine, center
shoulder and head joints), and spine (defined by center
hip, spine and center shoulder joints), using (4).
velocity =
√
v2x + v2y + v2z ≈
√
∆x2 + ∆y2 + ∆z2
∆t2
(1)
acceleration =
√
a2x + a2y + a2z ≈
√
∆vx
2 + ∆vy
2 + ∆vz
2
∆t2
(2)
distance = ‖−−−−−−−→PleftPright‖ (3)
angle = arccos
( −−−→
P2P1.
−−−→
P2P3
‖−−−→P2P1 ×−−−→P2P3‖
)
(4)
In (1), vx is the component of the velocity vector on the
x-axis for a given joint, and ∆x corresponds to the difference
between the x-coordinate values considering two consecutive
frames. In (2), ax is the component of the acceleration vector
on the x-axis for a given joint, and ∆vx refers to the difference
between velocities, on the x-axis, considering two consecutive
frames. Similar notations are used for the y- and z-axis.
In both (1) and (2), ∆t is the time elapsed between two
consecutive frames.
In (3), Pleft and Pright refer to the left and right
joint 3D positions, respectively. In (4), P1, P2 and P3
correspond to three different joint 3D positions. For example,
considering the angle at left knee, these points correspond
to the coordinates of the left hip, knee and ankle joints,
respectively.
A set of parameters, for each gait cycle, was then computed
over the obtained velocities, accelerations, distances and
angles: average, median, variance, and variance divided by the
average (normalized variance). This resulted in 136 different
parameters.
Additionally, the following four parameters were obtained,
for each gait cycle: gait cycle duration, stride length, stride
average velocity, and cadence. For the right leg, these param-
eters were computed using (5), (6), (7) and (8), respectively.
In (5) and (6), k corresponds to the gait cycle number. In
(6), PICR(k) and PICR(k+1) refer to the right ankle 3D
positions at instants ICR(k) and ICR(k + 1), respectively.
Similar equations were used for the left leg.
kth gait cycle duration = ICR(k + 1)− ICR(k) (5)
kth stride length = ‖−−−−−−−−−−−−−→PICR(k)PICR(k+1)‖ (6)
stride average velocity = stride length/gait cycle duration (7)
cadence = 1/gait cycle duration (8)
III. RESULTS
In order to evaluate which parameters can be used to
statistically distinguish between non-PD subjects, PD patients
in the STIM ON state and PD patients in the STIM OFF
state, we performed the Kruskal-Wallis test [13] for each
different parameter. The results (p < 0.05) for each dataset
(unfiltered and filtered) are presented in Table III, where the
lowest value for each case is indicated in bold.
Fig. 4 shows an example of the center shoulder velocity
versus the elapsed time, during a single gait cycle carried out
by subject C2 and patient P2 in the STIM OFF state, when
considering the filtered data. The corresponding variance
values are also indicated in Fig. 4.
TABLE III
KRUSKAL-WALLIS TEST RESULTS (p < 0.05), WHEN COMPARING
NON-PD, PD STIM ON AND PD STIM OFF STATES, FOR THE
UNFILTERED AND FILTERED DATASETS.
Parameter
p-valuea
Unfiltered Filtered
Variance
Velocity
Head N.S. 0.011
Center shoulder 0.027 0.004
Shoulder N.S. 0.021
Acceleration Center shoulder 0.042 0.016
Distance Elbows 0.019 0.024
Angle Elbow 0.046 N.S.
Normalized
variance
Velocity
Elbow N.S. 0.046
Center shoulder 0.009 0.006
Shoulder N.S. 0.039
Acceleration Center shoulder 0.041 0.008
Distance Elbows 0.024 0.024
Average Acceleration Center shoulder N.S. 0.041
Stride duration 0.045 0.045
Cadence 0.045 0.045
a N.S. means non-significant (p >= 0.05).
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Fig. 4. Velocity of the center shoulder versus the elapsed time, for a
gait cycle performed by subject C2 and patient P2 in STIM OFF state,
considering the filtered dataset. The associated variance values are also
included.
IV. DISCUSSION AND CONCLUSION
In this contribution, we used a system based on a single
sensor that minimizes intrusiveness, when compared with the
use of several sensors attached to the body in [6]. Similarly
to [5], we explored the possibility of both PD diagnosis and
follow-up based on gait analysis. However, in contrast with
[5], we relied on depth images and skeleton data based on
infrared light instead of common RGB images, which allowed
a less controlled environment (background color, lighting, and
subject clothing). Comparing with [8], we analyzed a greater
number of gait parameters, associated with all skeleton joints
provided by the Kinect. Moreover, we identified the most
appropriate parameter for PD assessment.
From Table III, we can see that filtering contributes to an
overall improvement of the parameters’ ability to statistically
distinguish between three different states: non-PD, PD STIM
ON, and PD STIM OFF. It can also be seen that the
variance of the center shoulder velocity seems to be the most
appropriate parameter for discriminating between the three
considered states (p = 0.004). From the example depicted in
Fig. 4, we can see that the value of this parameter is smaller
for the PD patient, when compared with the control subject.
This can be explained by the fact that PD patients tend to
walk slower, and therefore their walking speed does not reach
values as large as for healthy subjects.
The presented results show the potential of using a low-
cost RGB-D camera-based system for supporting both PD
diagnosis and follow-up, which can be very important for
early detection of PD and treatment outcome improvement.
Consequently, it can contribute to an increase of the patients’
quality of life, and a reduction of health care costs.
V. FUTURE WORK
Although the obtained results provide indications for using
RGB-D cameras to support PD assessment, more data are
required to confirm these preliminary indications. Acquisition
sessions with new subjects are already scheduled and the
associated results will be included in the next contribution.
Furthermore, we have now integrated the pre-release version
of the new Kinect for Windows v2 [14], which is expected
to have better overall characteristics, into the KinecTracker
application. This pre-release camera was awarded to our R&D
group as a “Developer Preview Program” member, and will
be used in the present system evolution.
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